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Specific objective 
The trpX gene is a little Streptomyces coelicolor orf, coding for a hypothetical 63-amino acids 
protein, TrpX , having, to date, unknown function. This gene is present in the trpA/B/X/C1 
operon, coding for important enzymes involved in the tryptphan biosynthesis pathway. 
The specific objective of this work is to start the study of the trpX gene role in Streptomyces 
coelicolor. In particular to: 
1) study the trpX expression in the strain S. coelicolor A3(2) M145, in various growth phases 
and media by qRT-PCR. 
2) perform in silico analysis of protein structure using the Robetta server. 
3) carry out EMSA of intergenic regions of trpA/B/X/C1 operon with crude extract of wt and 
mutant strains. 
4) overexpress and purify TrpX protein from E. coli. 
5) overexpress the trpX gene in S. coelicolor 
 
 
Results 
Real-Time RT-PCR analysis showed that trpX is not costitutively expressed during the growth in 
minimal medium, but is growth-phase dependent. 
In silico approaches and previous experiments have shown that TrpX protein is a putative 
regulator of the trpB gene, a gene involved in the tryptophan biosynthesis and a tridimentional 
structure prediction showed that TrpX protein could have a DNA-binding protein structure. The 
most probable hypothesis of the TrpX protein function in S. coelicolor, is that it binds to 
intergenic regions of the trpA/B/X/C1 operon, regulating the trpB gene expression. This 
hypothesis has not been confirmed by DNA binding assays carried out in this work, thus, further 
DNA or RNA binding assays are necessary. The His6-TrpX protein was successfully 
overproduced in E. coli, and its purification at present is in progress, it will be used in DNA or 
RNA binding assays, in order to confirm the previous hypothesis. 
The trpX gene overexpression in S. coelicolor, indicating ways to understand trpX function has 
not been obtained, but new strategies at present are in progess. 
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regulation,  trpX, SCO2038, electrophoretic mobility shift assay, qRT-PCR, cloning 
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Stratégies pour l’étude du rôle du gène trpX 
dans la souche Streptomyces coelicolor 
 
 
 
 
Objectifs spécifiques 
Le gène trpX est une petite orf de la souche Streptomyces coelicolor, qui code pour une 
protéine hypothétique de 63 acides aminés, TrpX, ayant à ce jour, aucune fonction connue. Ce 
gène est présent dans l’opéron trpA/B/X/C1, codant pour d’importantes protéines impliquées 
dans le pathway de la biosynthèse du tryptophane, un acide aminé aromatique. 
L’objectif spécifique de ce travail est l’étude du gène trpX dans la souche S. coelicolor. En 
particulier : 
1) l’étude de l’expression du gène trpX dans la souche S. coelicolor, dans différentes phase de 
croissance et milieux de culture, par qRT-PCR. 
2) l’analyse de la structure de la protéine TrpX, in silico, avec le programme informatique 
Robetta server. 
3) effectuer des EMSAs sur les régions intergéniques de l’opéron trpA/B/X/C1, avec des extraits 
protéiques brutes des souche de S. coelicolor wt et de mutants trpX. 
4) surexprimer et purifier la protéine TrpX produite dans une souche E. coli. 
5) surexprimer le gène trpX dans la souche S. coelicolor 
 
 
Résultats 
Une analyse par Real-Time RT-PCR a montré que le gène trpX n’est pas exprimer 
constitutivement mais est dépendant de la phase de croissance. 
Une approche in silico et des analyses précédentes à ce travail, ont montrés que la protéine 
TrpX est un possible régulateur du gène trpB, un gène impliqué dans la biosynthèse du 
tryptophane et une prédiction de la stucture tridimensionnelle de TrpX a montré qu’il s’agit d’une 
protéine liant l’ADN. L’hypothèse la plus probable du rôle de la protéine TrpX dans S. coelicolor, 
est qu’elle lie une région intergénique de l’opéron trpA/B/X/C1, régulant l’expression génique du 
gène trpB. Cette hypothèse n’a pas été confirmée par les analyses effectuées durant ce travail 
(DNA binding assays), donc d’autres essais sont nécessaires, notamment des DNA or RNA 
binding assays avec des conditions différentes. La protéine His6-TrpX a été surproduite, avec 
succès, dans E. coli, et sa purification est, à l’heure actuelle, en cours. Cette protéine purifiée 
pourra être utilisée dans des  
DNA or RNA binding assays, afin de confirmer l’hypothèse émise précédemment. 
La surexpression du gène trpX dans S. coelicolor, permettant d’indiquer des voies, afin de 
comprendre la fonction de trpX n’as pas été obtenues, mais de nouvelles stratégies ont été 
étudiées et sont désormais en cours. 
 
Mot-clés 
Projet ActinoGEN, Streptomyces coelicolor, antibiotique, tryptophane, pathway, cluster, opéron, 
régulation,  trpX, SCO2038, electrophoretic mobility shift assay, qRT-PCR, clonage 
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Abstract 
The emergence of several pathogenic bacteria and the adaptation of part of those resistant to antibiotics 
currently used, in clinically treatments, needs the research for new antibiotic development and the creation of 
a “Superhost”, allowing a large scale production of antibiotics. Streptomyces belongs to Actinomycetes , a 
group of gram-positive bacteria, producing more than 50% of known antibiotics. To increase antibiotic level 
production in these organisms,  the pathway of antibiotic precursors, like tryptophan, must be studied. 
The trpX gene is a little Streptomyces coelicolor orf, coding for a hypothetical 63-amino acids protein, TrpX , 
having, to date, unknown function. This gene is present in the trpA/B/X/C1 operon, coding for important 
enzymes involved in the tryptphan biosynthesis pathway, a aromatic amino acid. 
Real-Time RT-PCR analysis showed that trpX is not costitutively expressed during the growth in minimal 
medium, but is growth-phase dependent. 
In silico approaches and previous experiments have shown that TrpX protein is a putative regulator of the 
trpB gene, a gene involved in the tryptophan biosynthesis and a tridimentional structure prediction showed 
that TrpX protein could have a DNA-binding protein structure. The most probable hypothesis of the TrpX 
protein function in S. coelicolor, is that it binds to intergenic regions of the trpA/B/X/C1 operon, regulating 
the trpB gene expression. This hypothesis has not been confirmed by DNA binding assays carried out in this 
work, thus, further DNA or RNA binding assays are necessary. The His6-TrpX protein was successfully 
overproduced in E. coli, and its purification at present is in progress, it will be used in DNA or RNA binding 
assays, in order to confirm the previous hypothesis. 
The trpX gene overexpression in S. coelicolor, indicating ways to understand trpX function, has not been 
obtained, but new strategies at present are in progess. 
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1 INTRODUCTION 
1.1 The ActinoGEN project 
Title : Integrating genomics-based applications to exploit actinomycetes as a resource for 
new antibiotics 
Acronym : ActinoGEN 
Coordinator : Dr. Paul Dyson, University of Wales Swansea, UK 
 
ActinoGEN is an European integrated project aimed at developing novel genomics-based 
approaches to exploit hitherto overlooked genetic resources for new antibiotics. Drug 
discovery will focus on accessing new antibiotic biosynthetic pathways from diverse 
actinomycetes that have yet cultured; activating cryptic pathways from well-characterized 
actinomycetes; and engineering novel hybrid antibiotics by combinatorial biosynthesis.  
To accelerate drug discovery, another parallel strategy could be to engineer generic hosts 
optimized to produce high antibiotic yields, these hosts are called “Superhosts”. Indeed, a 
rate-limiting step to developing new antibiotics is yield improvement. Post-genomic 
analyses permit for the first time, a concerted and holistic approach to engineering generic 
Superhosts for use in the production of high yields of a wide variety of antibiotics. 
This synergy of discovery linked to overproduction will place the European biotechnology 
sector at the forefront of developing much-needed new antibiotics for fighting multi-drug 
resistant pathogens. 
ActinoGEN is a consortium made up of groups of 14 universities and 4 SMEs from 9 
different countries, UK, Czech Republic, Danemark, Germany, Italy, Netherlands, France, 
Switzerland and Spain. 
This work is in the fields of research aiming at creating a Superhosts, for high yields 
production of antibiotics. 
1.2 The Streptomyces genus 
1.2.1 General information on Streptomyces genus 
Streptomyces is the largest genus of Actinobacteria, a group of gram-positive bacteria. 
Streptomycetes are organisms widely spread in nature and in particular in the soil and the 
decaying vegetation where they act in the natural decomposition process and thus in the 
carbon cycle. 
 
The Streptomyces genus is characterized by a genome with high G+C content (69-78%), a 
large linear chromosome (approximately 8.7 Mb) and a complex life cycle. In addition to a 
morphological differentiation, Streptomyces undergoes a physiological differentiation on 
the basis of which, in given conditions of growth, they produce a vast range of secondary 
metabolites. These have many applications in the medical field, due to their employment 
like antibiotics, immunosuppressors and antitumoral agents, and in the agricultural field as 
weedkillers and pesticides. It could be estimated than more of 50% of 11,900 known 
antibiotics, are produced by Streptomyces (Kieser T, 2000). Each year, about 500 new 
antibiotics are identified and a lot of these come from Streptomyces genus. For this reason, 
streptomycetes have a great importance for pharmaceutical industry. (Hodgson DA, 2000) 
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1.2.2 Natural environment and life cycle of Streptomyces 
genus 
The soil, Streptomyces natural environment, is rich in carbohydrates and poor in phosphate 
and nitrogen, in fact, the greater source of nutriment derives from dead plants. Moreover 
due to the presence of many competitor microorganisms, the ground is an oligotrophic 
environment. Streptomycetes are saprophytes and produced extracellular enzymes, used in 
wall digestion of plant cells and insoluble polymers. They behave like facultative 
oligotrophic, because they have possibility to growth in a poor (oligotrophic) or a rich 
(copiotrophic) nourishing medium. (Hodgson DA, 2000) 
 
The growth of Streptomyces colony begins with spore germination in answer to easily 
assimilable soluble nutrients, which are used to form the vegetative mycelium. When these 
nutrients start to lack, the colony begins to produce lytic enzymes (e.g. cellulases and 
xylanases) for insoluble polymer degradation, generally dead plant tissues. During this 
same phase, the antibiotic production starts because it becomes crucial for the colony to 
protect, from other competitor microorganisms, nutrients which were previously 
solubilised (fig. 1).  
 
 
Figure 1  Vertical section of a colony of Streptomyces (Chater KF, 2006). 
Moreover, in response to lacking nutrients, the colony starts producing an aerial mycelium. 
(fig. 2) (Chater KF, 2006). 
 
 
Figure 2   Life cycle of a Streptomyces colony (Chater KC, 1998). 
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The aerial mycelium septate to form spores, which allow the colonization of neighboring 
zones by the bacterium. This colonization is carried out by spore transport performed by 
the wind, by arthropods, or by organisms which nourish from microbes present on the 
decaying plants. 
The growth of a Streptomyces colony is diauxic. On solid medium, in the first rapide 
growth phase (RG1), the colony produces the vegetative mycelium and in the second rapid 
growth phase (RG2), the aerial mycelium. In the transition phase (T), the colony growth is 
slowed down and the secondary metabolite production initiates and continues in the RG2 
and stationary (S) phases (fig. 3). In liquid medium Streptomyces does not differentiate in 
aerial mycelium and spores. 
 
 
Figure 3  Growth curve of Streptomyces coelicolor (Granozzi C, 1990). 
1.3 The Streptomyces coelicolor A3(2) genome 
The Streptomyces mycelium is cenocytic, each hypha containing multiple chromosome 
copy, spores, instead contain only one copy of the chromosome. 
The chromosome of Streptomyces coelicolor is linear. This characteristic confers a certain 
instability to the genome and thus a strong tendency to undergo, spontaneously, to 
deletions of DNA fragments, especially in the telomeric region. These deletions seem to be 
caused by transposition of DNA mobile elements (Volff JN, 1998). S. coelicolor genome, 
is the most characterized of all streptomycetes, the chromosome having been sequenced 
completely. This chromosome has a size of 8.7 Mb. 
The origin of replication, oriC, is located in the chromosome center (Bentley SD, 2002). At 
the two ends of the chromosome, there are terminal inverted repeated sequences (TIRs) 
which carry proteins bounded to their free 5’-ends. The replication of the genome is carried 
out bidirectionally starting from the oriC and leaves a gap after the last RNA primer 
elimination. This gap is then filled by a DNA synthesis, starting from proteins being at the 
end. This mechanism has been called “end-patching”. (Bao K, 2001) 
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With 7’825 identified genes, the chromosome of S. coelicolor has an enormous codifying 
potential. The gene distribution appears uniform along the chromosome, with a c.a. 4.9 Mb 
central core and two arms of 1.5 Mb for the left arm and 2.3 Mb for the right arm (fig. 4). 
 
Figure 4  Circular map of the genome of S. coelicolor (Bentley SD, 2002). 
Almost all genes present in the core are essential for the cellular division, DNA replication, 
transcription and translation and amino acids biosynthesis. Instead, contingency genes, 
codifying for non essential functions, like secondary metabolites and hydrolytic enzymes, 
reside in the arms. It has been found a correspondence between the core of the genome of 
S. coelicolor and the genome of the pathogenic bacterium Mycobacterium tuberculosis, 
indicating that the two microorganisms can have common ancestors, and S. coelicolor 
genome arms correspond to DNA acquired successively. (Bentley SD, 2002) 
Through analysis of global gene expression, using DNA microarray, it has been pointed 
out that during the vegetative growth, genes involved in the primary metabolism, are 
mainly expressed, both in rich or minimal medium. When the stationary growth phase 
starts, the gene expression in the core decreases, contrary to genes present in arms, which 
are more expressed (Karoonuthaisiri N, 2005). The proteins having regulatory function are 
approximately 965. S. coelicolor has, moreover, numerous regulatory two components 
systems (Bentley SD, 2002). 
1.4 Primary metabolism 
The primary metabolism includes all catabolic and anabolic reactions or pathways, which 
carry to a cell growth and thus an increase of the biomass (Hodgson DA, 2000). 
Many carbohydrate catabolic pathways are inducible. In substrate absence, a repressor 
binds to the promoter region of the catabolic operon and blocks the expression of the 
operon. For example, in S. coelicolor the operon of the glycerol catabolism is activated 
through an inducer, the glycerol-3-phosphate, produced by a kinase, activated when high 
level of glycerol is present in the medium (Seno ET, 1983).  
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When the natural environment of streptomycetes, the soil, contains nitrogen sources, like 
ammonium, glutamate, glutamine or nitrate, cells start using these compounds for their 
growth.  
When these substances start to lack, the cell begin the degradation of some amino acids 
and nucleotides, in order to have nitrogen sources. The soil, is generally poor in nitrogen, 
this is the reason why these pathways are for half constitutive and for half inducible. 
(Hodgson DA, 2000) 
The arginine catabolism needs the presence of the ornitine aminotransferase enzyme. This 
enzyme is constitutive but is repressed by ammonium and aspartate (Bascaran V, 1989). 
The catabolic pathway of tryptophan has been identified, for the first time, in S.parvulus 
(Katz E, 1984). The first enzyme of the catabolic pathway is the tryptophan dioxygenase, 
which is not induced and not repressed by tryptophan. On the contrary its activity is 
increased during the antibiotic actinomycin D, biosynthesis, thanks to a glutamate presence 
into the medium,. In bacteria, the majority of amino acid biosynthetic pathways are 
repressed by feedback repression, the final product repressing biosynthetic genes. 
Streptomycetes, seems to have lost or then not to have never evolved mechanisms of 
repression of amino acids biosynthesis. This is probably due to the fact that the soil is 
generally poor in amino acids. Indeed, there exist only three examples of feedback 
repression system : aromatic amino acids biosynthesis (Murphy MF, 1980); arginine 
biosynthesis (Flett F, 1987); aliphatic amino acids biosynthesis (Potter CA, 1996). It thus 
seems that streptomycetes have a reduced capacity to modify their primary metabolism, 
because of their oligotrofic natural environment. (Hodgson DA, 2000) 
1.5 Tryptophan biosynthetic pathway 
Studies carried out on auxotrophic strains of Streptomyces coelicolor allowed the 
identification of genes involved in the tryptophan biosynthesis, which are trpA, trpB, trpC, 
trpD, trpE, trpG and hisA. Some of these genes, like trpC, trpD and trpE have paralogue 
genes. 
The genes trpC2, trpD2, trpG and trpE2 belong to an operon internal to the cluster of the 
calcium dependent antibiotic (CDA) biosynthesis. The other trp gene are in three different 
clusters. The cluster which contains the s trpA, trpB and trpC genes, contains also the trpX 
(SCO2038) gene, a small orf, which would code for a 63 amino-acids peptide with 
unknown function (fig. 5). (Hu DSJ, 1999) 
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Figure 5   Schematization of genes for tryptophan biosynthesis in  
                S. coelicolor. 
The roles of various genes implied in the tryptophan biosynthesis are described hereafter : 
 
 trpE1/2/3 and trpG code for the anthranilate synthase. The trpG gene codes for a 
glutamine amidotransferase, its function being, in physiologic condition, to provide 
ammonium from glutamine. This reaction occurs, with lowest efficiency, without 
amidotransferase at alkaline pH, so that trpG is not essential. (Zalkin H, 1998) 
 trpD1/2 code for the anthranilate phosphoribosyl transferase, which catalyzes the 
formation of phosphoribosyl anthranilate, in the presence of anthranilate and 5-
phosphoribosyl-1-pyrophosphate. 
 hisA codes for the N-(5’-phosphoribosyl)-anthranilate isomerase, which catalyzes 
the tranformation of phosphoribosyl anthranilate in 1-(O-carboxyphenylamino)-1-
deoxyribulose-5-phosphate. The hisA gene is also involved in the histidine 
biosynthesis. 
 trpC1/2 code for the indole-3-glycerol-phosphate synthetase, an enzyme catalyzing 
the synthesis of indole-3-glycerol phosphate from 1-(O-carboxyphenylamino)-1-
deoxyribulose-5-phosphate. 
 trpA and trpB code for the tryptophan synthase. The trpA gene codes for the α-
subunit of the enzyme, responsible for the conversion of indole-3-glycerol 
phosphate in indole and glyceraldehydes-3-phosphate. The α-subunit forms a 
complex with β-subunit encoded by trpB, catalyzing the formation of L-tryptophan, 
from indole and L-serine. 
 
Aromatic amino acids (tryptophan, phenylalanine, tyrosine) are synthesized by a common 
precursor, chorismate, produced by the shikimate pathway, identified in all streptomycetes 
analysed. (Hodgson,2000) 
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The tryptophan pathway requires initially the synthesis of anthranilate from chorismate by 
anthranilate synthase. The mechanism of this reaction is an enolpyruvic elimination 
accompanied with an ammonium transfer of a glutamine. Then, there is the addition of the 
phosphorybosyl functional group of 5-phosphoribosyl-1-pyrophosphate in 3’ position of 
anthranilate, catalyzed by anthranilate phosphoribosyl transferase. This product is 
transformed in 1-(O-carboxyphenylamino)-1-deoxyribulose-5-phosphate by N-(5’-
phosphoribosyl)-anthranilate isomerase by rearrangement of phosphoribosyl-anthranilate. 
The indole-3-glycerol-phosphate synthetase then synthesizes indole-3-glycerol phosphate, 
by decarboxylation and closing of the ring. The last reaction is the suppression of the 
lateral chain of glycerophophate of indole-3-glycerol phosphate and its substitution with 
the alaninic group of L-serine, by tryptophan synthase, leading to the final product, the 
tryptophan (fig. 6). 
 
 
Figure 6   Schematization of the tryptophan biosynthetic pathway. 
1.6 Regulation of tryptophan biosynthetic genes 
The tryptophan biosynthesis requires a great amount of energy, so in bacteria it is finely 
regulated. Generally, in bacteria, the regulation of tryptophan biosynthetic gene is 
performed by attenuation mechanism and is based on the possibility to form hairpin 
structures, using a peptide-leader region, downstream of trp operon, that can form 
secondary structures, during the translation of the tryptophan operon. The regulation 
mechanism of the tryptophan biosynthesis has been extensively studied in various 
organisms, such as Escherichia coli and Bacillus subtilis (Yanofsky C, 2000). 
 
Expression of tryptophan biosynthetic genes in E. coli is regulated by two mechanisms. 
The first one is regulated via TrpR protein, encoded by trpR gene. This protein can have 
two different conformations, depending on the binding of tryptophan (the corepressor) with 
this protein. When TrpR is bound to tryptophan, it acts as a repressor for tryptophan 
biosynthesis, binding to the trp operon operator-promoter region. This regulation is thus 
dependent on the tryptophan concentration in the cell. When the concentration of 
tryptophan is high, it can bind to TrpR (Zurawski G, 1978). 
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The second mechanism has been called attenuation and it is due to a peptide-leader region 
transcribed downstream of trp operon and containing two codons for the tryptophan amino 
acid. The transcriptional regulation of the trp operon is thus dependent on the leader region 
translation, regulated by tryptophan into the cell (Yanofsky C, 2004). 
 
The Bacillus subtilis trpEDCFBA operon contains six of the seven genes required for the 
biosynthesis of tryptophan from chorismate, the common aromatic amino acid precursor. 
pabA (trpG), the remaining tryptophan biosynthetic gene, is present in an operon whose 
genes are primarily involved in folic acid biosynthesis. Expression of the B. subtilis 
tryptophan biosynthetic genes (trpEDCFBA) is regulated in response to tryptophan by the 
trp RNA-binding attenuation protein (TRAP), encoded by the mtrB gene. In presence of 
high concentration of tryptophan, TRAP binds to the leader sequence of trp mRNA and 
induce the formation of the transcription termination structure by hairspin structure 
formation. When concentration of tryptophan in the cell is low, TRAP does not bind to the 
leader sequence and an antitermination structure forms. This mechanism is relatively 
similar to that present in E. coli. 
TRAP-mediated regulation of the tryptophan biosynthetic genes includes also another 
distinct translation control mechanisms. TRAP regulates translation of trpP (yhaG), a 
single-gene operon that encodes a putative tryptophan transporter, and pabA (trpG) gene. 
TRAP binds specifically to a segment of the trpP and pabA transcript that includes the 
untranslated leader and translation initiation region. The tryptophan-activated TRAP 
regulates translation of trpP and pabA by preventing binding of a 30S ribosomal subunit or 
by blocking ribosome binding on the trpP and pabA mRNAs. (Yakhnin H, 2004) 
The regulation mechanisms of the trp operon in Streptomyces coelicolor are still unknown. 
Two potential sites of transcription initiation of the trpCXBA operon, however have been 
identified, the first upstream of trpC gene and the other upstream of trpX gene. The 
regulation of tryptophan biosynthetic genes in S. coelicolor does not seem to be due to 
feedback mechanism, but rather growth phase-dependent and growth rate-dependent. In 
fact, the trp operon is more massively expressed during the first exponential phase (RG1) 
and decreases during the second exponential phase (RG2) (Hogdson DA, 2000 ; Hu DSJ, 
1999). 
1.7 Secondary metabolism and antibiotic 
production 
1.7.1 Antibiotic production in S. coelicolor 
The secondary metabolism contains all reactions carrying to the biosynthesis of non-
essential, but useful, substances for the cell. Generally secondary metabolites are produced 
in large amount during the stationary phase or slow growth phases. 
Antibiotics are secondary metabolites and one can estimate than more of 50% of 11,900 
antibiotics today known, are produced by Streptomyces (Kieser T, 2000). S. coelicolor 
produces several antibiotics, the most characterized being the actinorhodin, the 
undecylprodigiosin and the calcium dependent antibiotic (CDA). The actinorhodin 
polyketide (ACT) gives a characteristic blue color to Streptomyces colonies and to the 
surrounding medium (from where the name coelicolor). The undecylprodigiosin (RED) is 
a non-diffusible antibiotic which gives a red pigmentation to the mycelium. (Hopwood, 
1999) The CDA belongs to the group of lipopeptidic acid antibiotics. 
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Through microarray analysis, the relation between the growth phase and the antibiotic 
production in the strain S. coelicolor M145, has been evaluated (fig. 7). (Huang, 2001) 
 
 
Figure 7   Growth of Streptomyces coelicolor A3(2) strain M145 in liquid 
    R5−medium and production of antibiotics (Huang, 2001). 
CDA and RED antibiotic production starts during the transition phase (T), whereas the 
ACT antibiotic is not produced before the stationary phase (S). 
The biosynthesis of secondary metabolites is influenced by a huge variety of signals, as 
much extracellular than intracellular. The expression of their biosynthetic cluster is 
controlled by various families of regulatory proteins, a great part of them belonging to the 
SARP family (Bibb MJ, 2005). An example of this phenomenon is RelA, the synthetase of 
highly phosphoryl guanilic nucleotide (ppGpp), associated to the ribosome, which is used 
for the antibiotic production under nitrogen limiting conditions in S. coelicolor 
(Chakraburtty R, 1997). The secondary metabolites biosynthesis can also be influenced by 
the availability of primary metabolism products and is triggered by several stressful 
conditions. 
1.7.2 Calcium dependent antibiotic (CDA) 
The calcium dependent antibiotic (CDA) belongs to the class of the natural products called 
non-ribosomal polypeptides (Kim HB, 2004). It is a lipopeptide formed by a cyclic peptide 
of eleven amino-acids, with the fatty acid 2,3-ipoxyexanol in the N-terminal position of the 
side chains (fig. 8). (Hojati Z, 2002) 
 
Figure 8   Structure of CDA isolated from S. coelicolor (Hojati Z, 2002). 
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The CDA acts against a vast range of Gram positive bacteria, but only in presence of 
calcium ions (for this reason is called calcium dependent). Calcium ions (Ca2+) allow an 
aggregation of several CDA molecules, through interactions between acid residues. This 
brings to the formation of a transmembrane canal in the bacterial membrane (Hopwood 
DA, 1983; Grunewald J, 2003). 
Recently the metabolic network responsible for the production of CDA, which includes 
more than 400 enzymatic reactions has been built (Kim HB, 2004).  
Genes codifying these enzymes are organized in a 82 Kb cluster, also containing genes 
implied in the CDA regulation and transport, for a total of 40 orf. This cluster is localised 
in the central region (core) of the Streptomyces coelicolor chromosome (Chong PP, 1998; 
Bentley SD, 2002). 
Inside the CDA cluster there is an operon containing some genes potentially involved in 
tryptophan biosynthesis. The trpC2, trpD2 and trpE2 genes are analogues to other genes 
present in the chromosome, outside the cluster, whereas the trpG gene is present in a single 
copy. In the center of the CDA cluster there is three long genes (cdaPS1/2/3), codifying for 
CdaPS1, 2 and 3, non-ribosomal peptide synthetases (NPRS), allowing the CDA 
biosynthesis (fig. 9) (Hojati Z, 2002). 
 
 
Figure 9   CDA biosynthetic cluster in S. coelicolor (Hojati Z, 2002). 
The NPRS biosynthesis requires some primary metabolites, necessary for the growth; in 
fact, these precursors are (Kim HB, 2004) : 
- Coenzyme-A deriving from fatty acids metabolism 
- Mevalonate deriving from Acetyl-CoA 
- Nucleotides 
- Carbon sources (sugars) 
- Shikimate 
- Amino acids (mainly tyrosine, aspartate, tryptophan, threonine, glycine, serine, 
glutamate and oxoglutarate) 
The CDA synthesis rate has been analyzed studying the effect of mutations in genes which 
code for enzymes involved in the production of primary metabolites, precursors of CDA. 
The CDA production was increased intervening on the assimilation way of the nitrogen, on 
the pentose phosphate pathway and also on oxoglutarate flow. (Kim HB, 2004) 
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2 MATERIALS AND METHODS 
2.1 Strains and plasmids 
Table 1  Strains and plasmids used in this study. 
Strains and 
plasmids Relevant genotype 
Source or 
reference Acronym 
E. coli strains    
DH5α F
-Φ80dlacZΔM15Δ(lacZY A-argF)U169 endA1 
recA1 hdsR17 deoR thi-1 supE44 λ- gyrA96 rel1A1 (Hanahan D, 1983) DH5α 
BL21(DE3) pLysS F
- ompT hsdSB (rB- mB-) gal dcm (DE3) pLysS 
(CamR) araB::T7RNAP-tetA (Studier FW, 1986) BL21 
S. coelicolor strains    
M145 Wild type, SCP1–, SCP2– (Kieser T, 2000) M145 
M145 trpX::Tn5062 M145 trpX::Tn5062 UNIPA ΔX 
M145 trpX::Tn5062 
/pKCHyg796 M145 trpX::Tn5062 pKC796Hyg UNIPA ΔX/pKC 
M145 trpX::Tn5062 
/pKCHyg796trpX M145 trpX::Tn5062 pKCHyg796trpX UNIPA ΔX/X 
Plasmids    
pGEM®-T easy lacZ, Ampr Promega pGEM 
pGEM-trpX pGEM®-T carrying trpX UNIPA pGEM-X 
pRSETB T7 promotor, N-terminal His6 tag, Ampr Invitrogen pRSETB 
pRSETB-trpX pRSETB carrying trpX  This study pRSETB-X 
pIJ8600 tipAp, tsr, aprr, int/xis oriT, attP John Innes Center pIJ8600 
pIJ8600-trpX pIJ8600 carrying trpX This study pIJ-X 
2.1.1 E. coli 
2.1.1.1 E. coli DH5α and E. coli DH5α pGEM-X 
The strain E. coli DH5α is a well known strain used for cloning. Its genotype is F-
Φ80dlacZΔM15Δ(lacZY A-argF)U169 endA1 recA1 hdsR17 deoR thi-1 supE44 λ- 
gyrA96 rel1A1 (Hanahan D, 1983). 
The strain E. coli DH5α pGEM-X has been provided by UNIPA, Palermo, Italy. The 
pGEM-X plasmid has been construct by insertion of trpX in pGEM-T Easy™ (Promega), 
using BamHI and NdeI restriction sites. The trpX correct insertion has been guaranteed by 
DNA sequencing. 
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2.1.1.2 E. coli BL21(DE3) pLysS 
The genotype of E. coli BL21(DE3) pLysS is F- ompT hsdSB (rB- mB-) gal dcm (DE3) 
pLysS (CamR) araB::T7RNAP-tetA. (Studier FW, 1986) 
E. coli BL21 have a T7 bacteriophage RNA polymerase-based expression system, for high 
yield expression of recombinant proteins. This strain is a lisogen of λDE3 virus, it thus 
contains a copy of the gene encoding for the T7 RNA polymerase. The recombinant 
protein expression can be induced by IPTG. 
Another characteristic is a mutation in the gene rne131 coding for the RNase E enzyme, an 
essential endonuclease. This enzyme is involved in rRNA maturation and mRNA 
degradation, thus mRNAs expressed in E. coli BL21, have increased stability. 
The plasmid pLysS contains a gene encoding for the T7 lysozyme (lysS) and also a 
chloramphenicol resistance gene. 
2.1.2 Streptomyces coelicolor A3(2) 
The strain S. coelicolor A3(2) M145 trpX::Tn5062 has been constructed, on the basis of S. 
coelicolor A(3)2 M145, by trpX gene interruption using the 5062 transposon. The 
complementation of trpX in this mutant has been made using the recombinant plasmid 
pKCHyg796trpX (S. coelicolor A3(2) M145 trpX::Tn5062/pKCHyg796trpX). The strain 
S. coelicolor A3(2) M145 trpX::Tn5062/pKCHyg796 has been also constructed. 
2.1.3 pGEM®-T easy 
The pGEM®-T easy vector (A1360, Promega, Madison WI, USA) is a high copy number 
plasmid and it has been used for E. coli cloning. It also contains a resistance to ampicillin 
(ampr) gene (fig. 10). 
 
 
Figure 10   pGEM®-T Easy vector map (Promega, Cat. N° TM042). 
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2.1.4 pIJ8600 
The pIJ8600 plasmid has been built by John Innes Centre, Norwich, UK. It can be 
replicated in E. coli and it can be used for integration in the S. coelicolor chromosome and 
overexpression of a gene. It is characterised by the following element (fig. 11) : 
 A thiostreptone inducible promoter (tipAp) 
 A thiostreptone resistance gene (tsr) 
 A apramycin resistance gene (aprr) 
 A multiple cloning site (MCS) 
 int/xis gene coding for an integrase, useful for plasmid integration in S. coelicolor 
chromosome 
 oriT origine site, used for the conjugation 
 attP site homologous to attB sequence in S. coelicolor chromosome, used for a 
specific integration of the DNA insert 
 
 
 
 
Figure 11  pIJ8600 plasmid map  
 
 
 
 
 
 
 
 
2.1.5 pRSETB 
The pRSETB plasmid (V35120, Invitrogen, Carlsbad CA, USA) comes from a vector 
expression family derived from pUC and has been developed for recombinant protein 
overexpression in E. coli. The recombinant protein overexpression is possible due to a T7 
promoter. Moreover inserts are positioned downstream and in the reading frame of a N-
terminal fusion peptide coding sequence. This peptide sequence includes a ATG codon for 
the translation initiation and a polyhistidine tag. His-tag allows a simple purification of 
recombinant protein with a nickel containing resin (fig. 12). 
 
 
 
 
Figure 12  pRSETB plasmid map  
 
 
 
 
 
 
 
 
                           Diploma 2007                  
 
 
Ledda Mirko                                            04.03.2008                                                  17 / 57 
 
2.2 Culture medium 
2.2.1 Solid culture medium 
LB Agar Medium (also called LA Medium) 
Put 25 g of Luria Broth Base (Miller’s LB Broth Base, 12795, Invitrogen, Carlsbad CA, 
USA) in a 1 L bottle and add 10 g of Technical Agar. Complete to 1 L with demineralised 
water, mix and sterilise at 121°C for 20 min. 
2.2.2 Liquid culture medium 
LB Medium 
Put 25 g of Luria Broth Base (Miller’s LB Broth Base, 12795, Invitrogen, Carlsbad CA, 
USA) in a 1 L bottle and complete to 1 L with demineralised water, mix and sterilize at 
121°C for 20 min. 
2×YT Medium 
Product Mass [g] 
Difco Bacto tryptone 16 
Yeast Extract 10 
Sodium chloride (NaCl) 5 
 Complete to 1L with demineralised water 
 Sterilize at 121°C for 20 min 
SMMS Medium 
Product Quantity 
Casaminoacid 2 g 
TES 1M pH 7.6 50 ml 
NaH2PO4 50 mM 10 ml 
K2HPO4 50 mM 10 ml 
MgSO4 1 M 5 ml 
D-Glucose 50 % 18 ml 
Trace elements** 1 ml 
Tryptophan 7.5 mg/ml 7.5 ml 
** Trace elements for SMMS Medium : 0.1 g/l of ZnSO4∙7 H2O, FeSO4∙7 H2O, 
MnCl2∙4 H2O, CaCl2∙6 H2O and NaCl 
 
 Complete to 1 L with demineralised water  
 Sterilize at 121°C for 20 min 
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SpMR Medium 
Product Quantity 
Sucrose 103 g 
Magnesium chloride (MgCl2) 10 g 
D-Glucose 5 g 
Yeast Extract 5 g 
TES 1M pH 7.6 50 ml 
Trace elements* 2 ml 
 
* Trace elements for SpMR Medium : 0.6 mM ZnCl2, 0.12 mM CuCl2, 0.10 mM 
MnCl2, 0.05 mM Na2B4O7, 0.016 mM (NH4)6Mo7O24 
 
 Complete to 1 L with demineralised water  
 Sterilize at 121°C for 20 min 
 Add 2 ml of sterile CaCl2 5M 
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2.3 DNA Manipulation 
2.3.1 Agarose Gel Electrophoresis 
The DNA Agarose Gel Electrophoresis is used for DNA fragment separation using an 
electric current applied to a gel matrix. Indeed, the DNA (negatively charged) migrates 
inside the agarose gel towards the anode (positively charged). A small DNA fragment 
migrate more quickly than a larger one. The fragment separation is thus made by size and 
topology. The agarose has been solubilised in TAE buffer 1X and the gel electrophoresis 
has been made in a bath of TAE 1X. 
Ethidium bromide has been added to the gel (0.001% of the final gel volume) because it 
allows the DNA visualisation. The ethidium bromide have a planar circular structure and 
link to DNA by intercalation between nucleic bases. When ethidium bromide is bound to 
DNA, it can be excite with UV light, and it emits fluorescence. A DNA fragment size is 
determinated with a DNA ladder. DNA fragments can also be quantified by confronting 
the fluorescence intensity emitted by the ladder and the DNA sample. The ladder used has 
been GeneRuler™ DNA Ladder Mix (SM0332, Fermentas, Hanover MD, USA). A 6X 
loading buffer has been added to the samples, in a ratio of 1:5 (loading buffer : sample). 
TAE buffer 50X (Tris-Acetate-EDTA) 
242 g Tris BASE, 57.1 ml Acetic acid glacial and 100 ml EDTA (0.5 M, pH8.0) 
 Complete to 1 L with demineralised water 
 Adjust the pH to 8.5 
Loading buffer 6X 
30% Glycerol, 60 mM EDTA (ph 8.0) and 0.06% Bromophenol Blue and 0.06% Xylene 
cyanol 
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2.3.2 PCR 
The Polymerase chain reaction (PCR) is a technique of in vitro targeted DNA 
amplification. It allows to obtain, important amount of a specific DNA fragment. The 
amplification of DNA is carried out at the time of three steps repeated recurringly, after a 
first step of denaturation (initial denaturation) : 
 Denaturation at 95°C of dsDNA in ssDNA. 
 Annealing, step allowing to primers to bind the ssDNA. The temperature of 
annealing is determined by primer sequences. 
 Extension of DNA, starting from primers, by the Taq polymerase, at 72°C. 
The PCR has been made in the thermocycler Tpersonal® (050-550, Biometra, Goettingen, 
Germany). 
PCR amplification of trpX gene has been carried out in the master mix and with PCR 
conditions shown thereafter: 
Master mix (for 1 sample) 
Product Concentration Volume [µl] 
Buffer Taq 10X 5 
Magnesium chloride (MgCl2) 50 mM 1.5 
dNTP 10 mM 1 
Primer forward - 1 
Primer reverse - 1 
Taq Polymerase 5 U/µl 0.5 
DMSO - 5 
H2O demineralised - 33 
Final volume - 48 
 Add 2 µl of DNA 
Temperature and times of PCR steps 
5 min at 95°C → Initial denaturation 
N° Temp. [°C] 
Time 
[min] N° 
Temp. 
[°C] 
Time 
[min] N° 
Temp. 
[°C] 
Time 
[min]  
1 95°C 1 7 95°C 1 13 95°C 1  
2 64°C 1 8 60°C 1 14 56°C 1  
3 72°C 1 9 72°C 1 15 72°C 1  
4 95°C 1 10 95°C 1 16 95°C 1 
5 62°C 1 11 58°C 1 17 54°C 1 
6 72°C 1 12 72°C 1 18 72°C 1  
2.3.3 Colony pool PCR 
The colony pool PCR is a DNA amplification technique from a microorganism colony. 
Some cells taken from few colonies on a Petri dish are suspended in the PCR master mix. 
The cell lysis, and thus the release of DNA, are carried out during PCR steps. 
This method is typically used for the screening after a cloning, allowing to analyze several 
colonies in a single PCR tube. The colony pool PCR has been made in the thermocycler 
Tpersonal® (050-550, Biometra, Goettingen, Germany). Colony pool PCR amplification of 
trpX has been made with the conditions described in the PCR chapter. 
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2.3.4 Extraction of plasmid DNA 
2.3.4.1 MiniPrep extraction 
The MiniPrep protocol allows us to extract plasmid DNA from a liquid culture. Two 
methods have been used for this extraction. First method has been used for a high purity of 
plasmid DNA after extraction and has been made with the Kit GenElute™ Plasmid 
Miniprep (cat. n° PLN-10, Sigma-Aldrich, Steinheim, Germany). Handlings carried out are 
described in the protocol provided with the Kit. Second method allows to extract plasmid 
DNA, with a less cost compared to the commercial kit. The disadvantage is the poor 
quality of the plasmid DNA extracted. In fact, it contains, generally, a not negligible part 
of chromosomal DNA and proteins. The protocol used is shown hereafter : 
 
1. Pour 1.5 ml of culture in one Eppendorf tube and spin 10 min at 12’000 rpm. 
2. Discard the supernatant 
3. Suspend the pellet in 100 µl of Solution I and wait 5 min at room temperature (RT) 
This step weakens the cellular membrane 
4. Add 200 µl of Solution II, mix and keep on ice during 5 min 
This step permits the cell lysis and it is important to maintain the temperature at 4°C 
for not damage the DNA 
5. Add 150 µl of Solution III, mix gently and keep on ice during 5 min 
During this step, the pH of the solution returns to pH7 abruptly. The chromosomal 
DNA is not correctly renatured and thus precipitates with cell debris while most of 
plasmid DNA renatures remaining in solution 
6. Spin during 1-2 min at 4°C, take 400 µl of the supernatant and pour in another 
Eppendorf tube 
7. Add 2 volumes (800 µl) of cold ethanol 95%, mix and wait 10 min at RT 
8. Spin 5 min, discard the ethanol and dry the tube in a Speed Vacuum for 30 min 
It is possible air dry the tube on a piece of paper at room conditions 
9. Suspend the pellet in 30 µl of demineralised water 
Sometimes it is not possible to see a pellet, in this case wash well the wall of the 
eppendorf tube with the pipette 
 
Solution I  Solution II  Solution III 
Glucose 50 mM  NaOH 0.2 N  Potassium acetate 5 M 
Tris-HCl 
(pH8) 25 mM  SDS 1%  
Acetic acid 
glacial 28.75% 
SDS 1%  Prepare a fresh solution  Sterilize and stock at 4°C 
Sterilize and stock at 4°C       
2.3.4.2 MaxiPrep extraction 
The MaxiPrep extraction uses the same principle as the MiniPrep extraction, but the 
amount of plasmid DNA extracted is much higher. This extraction has been made with the 
Kit QIAGEN® Plasmid Maxi (12163, QIAGEN Sciences, Germantown MD, USA). 
Extraction has been carried out according manufacturer’s protocol. 
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2.3.5 Phenol-chloroform extraction 
The removal of proteins, from a DNA sample, is important because cells contain enzymes 
degrading nucleic acids or DNA binding proteins and can interfere with subsequent 
enzymatic treatments. The classic protocol uses a mixture of phenol and chloroform. The 
protocol used is shown below : 
 
1. If the volume is less than 50 µl, add demineralised water to arrive at this volume 
2. Add one volume of phenol-chloroform and mix vigorously vortexing 
The phenol permit to denaturate proteins which will precipitate now at the interphase 
3. Spin for 5-7 min at 13’000 rpm 
4. Recover the aqueous phase (the upper phase) 
Do not touch the interphase with the point of the pipette 
5. Add a identical volume of chloroform and mix 
6. Spin for 5-7 min at 13’000 rpm 
7. Recover the aqueous phase like as at the time of step 4 
8. Add 1/10 volume of sodium acetate 3M and 2 volumes of ethanol absolute 
9. Keep the sample at -80°C for 1 hour 
During this step the DNA precipitates 
10. Spin at 13’000 rpm for 20 min at 4°C and discard the supernatant 
11. Add 400 µl of ethanol 70% 
12. Spin at 13’000 rpm for 10 min at room temperature and discard the supernatant 
13. Dry the tube in a Speed Vacuum for 30 min 
It is possible air dry the tube on a piece of paper at room conditions 
14. Suspend the pellet in a appropriate volume of H20 demineralised 
Sometimes it is not possible to see a pellet, in this case wash well the wall of the 
eppendorf tube with the pipette 
2.3.6 Drop dialysis 
The drop dialysis is a simple and fast method to eliminate salts and other small molecules 
from a small DNA or protein sample volume. The elimination of salts in the sample is 
achieved by diffusion through the membrane, from the sample to an aqueous phase. 
It has been carried out by filling a container (typically a 100 mm Petri dish) with 
demineralised water, on which a floating filter disc Millipore “V” Series Membranes 
0.05µm (VMWP02500, Millipore, Billerica MA,USA) has been delicately deposited. 
When the filter has been wet, the sample, of a typical volume between 20 and 400 µl, has 
been deposited on the surface of the disc. The drop dialysis duration changes according to 
the sample volume and composition, but it generally lasted between 30 min and 1h. It is 
possible to add a marker dye to the sample to follow the purification process. 
                           Diploma 2007                  
 
 
Ledda Mirko                                            04.03.2008                                                  23 / 57 
 
2.3.7 Digestion with restriction enzymes 
Restriction enzyme amount used during a DNA digestion has been calculated in relation to 
the quantity of DNA to digest. One unit (1U) of enzyme allows, generally, to cut 1 µg of 
DNA in one hour. These amounts are efficient for a digestion at the optimal temperature of 
the enzyme (generally 37°C) and in the buffer provided with the enzyme (see the note 
provided during the purchase). Moreover, it is important to remember that the enzyme is 
stored in a solution containing glycerol, because problems of enzymatic activity can appear 
when the glycerol concentration during the digestion is higher than 4%. 
 
Restriction enzymes used 
 BamHI (10 U/µl), 15201-031, Invitrogen, Carlsbad CA, USA     
 DraI (10 U/µl), 526S, New England Biolabs, Beverly MA, USA     
 HindIII (10 U/µl), 15222-011, Invitrogen, Carlsbad CA, USA     
 NdeI (5U/µl), 15426-018, Invitrogen, Carlsbad CA, USA           
2.3.8 Alkaline phosphatase treatment 
During a ligation between a DNA insert and a vector, it is important to prevent the vector 
recircularization (self-ligation). The ligation asks for the presence of a 5’-ends phosphate 
group at least on one of the two DNA fragments to bind. During the alkaline phosphatase 
treatment, phosphate groups at 5’-ends of DNA fragments are removed, avoiding vector 
self-ligation. The alkaline phosphatase treatment has been carried out with Alkaline 
phosphatase (AP) (11097075001, Roche Diagnostics GmbH, Indianapolis IN, USA) during 
1h at 37°C. 
To calculate the right quantity of alkaline phosphatase to use for a DNA 
dephosphorylation, it is necessary to know the DNA extremity quantity in the sample. In 
fact, 1 U AP dephosphoryls 1 pmol DNA extremity in 1 h at 37°C. To calcultate the DNA 
extremity quantity in the sample, the following two calculations have been used : 
1) MWDNA = SDNA × 330 [g/mol] × StrandNb             2) DNAextr = (mDNA / MWDNA) × 2 
DNAextr : DNA extremity quantity in the sample in [pmol] 
mDNA : DNA quantity in the sample in [pg] 
MWDNA : Masse weight of DNA in the sample in [g/mol] 
SDNA : DNA size in [bp] 
StrandNb : Number of DNA strand (1 = ssDNA and 2 = dsDNA) 
330 [g/mol] = Average masse weight of a nucleotide 
2.3.9 Ligation 
The ligation is a reaction linking two DNA fragments. It allows, typically, to link an DNA 
insert to a vector. This reaction is carried out at room temperature, using an DNA ligase 
(T4 DNA Ligase, 15224-017, Invitrogen, Carlsbad CA, USA), during 1h. 
To obtain a correct ligation the presence of contaminant in the reaction solution should be 
avoid and the concentration of the two DNA fragments to be bound accurately calculated. 
For a ligation insert-vector, it is generally used a mass ratio insert : vector of 3:1. This 
mass ratio makes it possible to minimize the formation of vector-vector and insert-insert 
dimers, but can nevertheless be modified to optimize the reaction. 
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2.3.10 Preparation of calcium competent cells 
For the preparation of calcium competent cells, it is important to remember that the 
solutions and handling must be sterile. 
 
1. Prepare 3 ml of pre-inoculum in LB Medium with E. coli cells. Incubate over-night 
at 37°C 
2. Add the 3 ml of pre-inoculum to 200 ml of LB Medium in a 500 ml flask. Incubate 
at 37°C until the culture reaches an OD650nm = 0.6 
3. Pour the culture in 4 falcon tubes and keep 1-2h on ice 
4. Spin at 3’700 rpm during 7 min at room temperature 
5. Discard the supernatant and suspend the pellet in 25 ml sterile CaCl2 70mM (Pre-
cooled on ice) 
6. Put 1h on ice 
7. Spin at 3’400 rpm during 7 min at room temperature 
8. Discard the supernatant and suspend the pellet in 5 ml of freezing solution 
9. Join together the samples, and prepare 8 eppendorf tubes with 200 µl of the cells, 
16 eppendorf with 300 µl and 24 eppendorf with 400 µl 
10. Store at -80°C 
Freezing solution (for 20 ml) 
14.28 ml CaCl2 70mM, 4 ml Glycerol 100% and 1.72 ml sterile H2O 
2.3.11 Transformation of calcium competent cells 
Calcium cations (Ca2+) neutralize negative charges of phospholipids on the E. coli cellular 
membrane and allow the DNA molecules (Negatively charged too) to get closer to cell 
membrane. An abrupt change of the temperature (heat-shock) causes the formation of 
pores increasing thus, the permeability of the cell, allowing the plasmid to enter in the cell. 
The transformation of calcium competent cells protocol is presented to follow : 
 
1. Freeze sterile tubes 
2. Defrost calcium competent cells on ice 
Calcium competent cells are sensible, a too fast defrosting will risk to damage cells 
3. Add 200 µl of competent cells in a sterile tube 
4. Add 20 µl of the DNA after ligation 
5. Mix and keep tubes 40 min on ice 
6. Heat shock of cells at 37°C for 3 min 
The plasmid enters during this step. It is a critical step because cells are now very 
fragile, and a heat-shock prolonged could destroy the cellular membrane 
7. Add 1 ml of LB medium 
8. Keep tubes at 37°C for 1h 
9. Put 400 µl of LB containing cells on selective plates (3 selective plates for each 
ligation) 
10. Incubate at 37°C over night 
Not more than 20h! After this time, antibiotics do not have any more the same 
effectiveness, and it’s possible observe wrong clones 
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2.3.12 Preparation of electro-competent cells 
1. Prepare 5 ml of pre-inoculum in LB Medium with E. coli cells. Incubate over-night 
at 37°C 
2. Add the 3 ml of pre-inoculum to 500 ml of LB Medium in a 2l flask. Incubate at 
37°C until the culture reaches an OD650nm = 0.5 
3. Pour the culture flask 10-15 min on ice 
4. Pour the culture in a centrifuge bottle, spin 20min. at 2°C and 2500 g (Beckman 
JA-14 rotor), and discard the supernatant 
5. Resuspend cells in 5 ml HEPES (1 mM, pH 7) and add other 500 ml cold HEPES 
6. Well mix, spin at 2500 g during 20 min and discard the supernatant 
7. Resuspend cells in 500 ml cold demineralised water, spin spin at 2500 g during 20 
min and discard the supernatant 
8. Resuspend cells in the remaining liquid and pour 10 ml of suspension in four 50 ml 
Falcon tube 
9. Add 40 ml cold 10% glycerol and well mix 
10. Spin 10 min at 2°C and 2500 g (Beckman JA-20 rotor) and discard the supernatant 
11. Resuspend cells in the remaining liquid 
12. Aliquot 40 µl cells in 1.5 ml Eppendorf tube 
13. Freeze aliquots at -20°C and pour it 10 min in dry ice 
14. Stock cell aliquots at -80°C 
2.3.13 Transformation of electro-competent cells 
During the transformation of electro-competent E. coli cells, the electric field, created by a 
high voltage impulse (12.5-15 kV·cm-1), induces the pore formation in the cell membrane. 
DNA molecules can enter in cells, using cell membrane pores. 
 
1. Defrost electro-competent cells on ice 
Electro-competent cells are sensible, a too fast defrosting will risk to damage cells 
2. Add 2 µl of DNA after ligation to cells 
3. Set the electroporator MicroPulser™ (411BR, Bio-Rad, Hercules CA, USA) at 25 
µF, 2.5 kV and 200 ohm 
4. Pour DNA-cell suspension in a cold electroporation cuvette, insert it in the 
electroporator and give the electric impulse 
If too much salts are present in the cell suspension, that can generate an electric arc, 
the electric current passing through salts. If an electric arc is formed, cells are not 
affected, and it is necessary to repeat the transformation 
5. Immediately after the electric impulse, remove the electroporation cuvette and add 
1 ml of rich medium (like LB medium) to cells. 
It is necessary to add the rich medium as soon as possible, for avoid the diminution of 
cell viability 
6. Recover the cell suspension, pour it in a 1.5 ml sterile Eppendorf tube and keep at 
37°C during 1h 
7. Pour LB containing cells on selective plates (3 selective plates for each 
transformation) 
8. Incubate at 37°C over night 
Not more than 20h! After this time, antibiotics do not have any more the same 
effectiveness, and it’s possible observe wrong clones 
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2.4 Protein methods 
2.4.1 Protein structure prediction with Robetta server 
The Robetta server (http://robetta.bakerlab.org) provides automated tools for protein 
structure prediction and analysis. For structure prediction, sequences submitted to the 
server are parsed into putative domains and structural models are generated using either 
comparative modeling or de novo structure prediction methods. If a confident match to a 
protein of known structure is found using BLAST, PSI-BLAST, FFAS03 or 3D-Jury, it is 
used as a template for comparative modeling. If no match is found, structure predictions 
are made using the de novo Rosetta fragment insertion method. The detailed operation of 
the Robetta server is described by Kim DE, 2004. The result of the Robetta protein 
structure prediction is a series of possible models, where for each model, a series of known 
proteins, having a similar structure, is proposed. 
2.4.2 SDS-PAGE 
The SDS-PAGE (Sodium Dodecylsulphate – Polyacrylamide Gel Electrophoresis) is a 
protein electrophoresis on a polyacrylamide gel. This technique have the same principle of 
the DNA electrophoresis on agarose gel. It allows the protein separation according to their 
molecular weight. The gel is constituted from a three-dimensional polymer of 
polyacrylamide, obtained from the copolymerization of acrylamide and methylen-bis-
acrylamide, initiated from ammonium-persulphate (APS, initiator of the chain reaction) 
and TEMED (catalysator of the polymerization reaction). The SDS is a detergent and a 
strong ionic surfactant. It removes the non-covalent bond of proteins, allowing their 
denaturations, and thus the loss of their native folding. Moreover, SDS anions bind to 
proteins conferring a constant density of negative charges, independently of the molecular 
weight and amino acids composition. These conditions allows to obtain a separation only 
parameterized by the molecular weight of proteins. 
The β-mercaptoethanol is a reducer of disulfur bonds. The disulfur bonds are important for 
the tertiary structure of proteins, and the cleavage of these bonds allow the linearization of 
proteins. 
Before the SDS-PAGE analysis, the samples must be prepared. The samples are prepared 
in a 3X sample buffer (or loading buffer), in a ratio of 1:2 (loading buffer : sample), put 
during 5 min into a boiling water bath, followed by 5 min on ice. The high temperature 
facilitates the proteomic denaturation. 
The polyacrylamide gel is discontinuous : 
 Stacking Gel (wide meshes, in pH 6.8 buffer) 
The Stacking Gel allows the formation of a tight protein bands 
 Resolving Gel (tight meshes, in pH 6.8 buffer) 
The Resolving Gel allows the separation of proteins 
 
The SDS-PAGE analysis has been carried out with a polyacrylamide concentration of 
12%. 15 µl of BenchMark™ Pre-Stained Protein Ladder (10748-010, Invitrogen, Carlsbad 
CA, USA) has been charged in the gel. The run of the SDS-PAGE analysis has been made, 
in the Tris-Glycine buffer 1X, at 30 mA until appropriates separation of protein bands. 
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Sample buffer 3X 
150 mM Tris-HCl (pH 6.8), 300 mM DTT, 6% SDS, 0.3% bromophenol blue and 30% 
glycerol 
Tris-Glycine buffer 5X 
15 g Tris BASE, 72 g Glycine and 10 ml SDS 10% 
 Complete to 1 L with demineralised water 
Stacking Gel 5% (for 4 ml) 
Product Volume [ml] 
H20 demineralised 2.7 
Acrylamide Mix 30% 0.67 
Tris 1M (pH 6.8) 0.5 
SDS 10% 0.04 
Ammonium persulphate 10% 0.04 
TEMED 0.004 
Resolving Gel 12% (for 10 ml) 
Product Volume [ml] 
H20 demineralised 3.3 
Acrylamide Mix 30% 4 
Tris 1.5M (pH 8.8) 2.5 
SDS 10% 0.1 
Ammonium persulphate 10% 0.1 
TEMED 0.004 
 
The gel coloration has been made for minimum 1h (generally 1h30-2h), in Coomassie 
staining solution. After this step, the staining solution has been removed (it’s possible to 
re-use the Coomassie staining solution as long as the color is sharp) and the gel has been 
washed with demineralised water. Afterward, the gel has been put in a bath of destaining 
solution and quietly shaken until discoloration of the gel (generally 3h or more).  
 
Coomassie staining solution (for 1 l )  Destaining solution (for 1 l ) 
Product Volume [ml]  Product Volume [ml] 
Methanol 225  Methanol 225 
Acetic acid glacial 50  Acetic acid glacial 50 
Coomassie Blue G250 1    
 Complete to 1 l with demineralised water 
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2.4.3 Protein quantification with Bradford assay 
The Bradford Protein Assay, is a spectroscopic analytical procedure used to measure the 
protein concentration in a solution. The Bradford assay, a colorimetric protein assay, is 
based on the absorbance shift of the Coomassie dye. Proteins bind to the green and red 
Coomassie and forms the blue Coomassie form. The blue form have a maximal absorbance 
spectrum at 595 nm. The absorbance increase, at 595 nm, is proportional to the amount of 
bounded dye, and thus to the protein amount (concentration) in the sample. The analysis 
has been done with the following protocol : 
1. Build a calibration curve with BSA at known concentration on the desired scale 
(generally a scale between 0 and 200 µg/ml). To do that, add 200 µl of the sample 
to 800 µl of Bradford reagent, mix, wait 5 min. and read the OD595nm. 
2. Add 200 µl of the protein sample to analysis to 800 µl of Bradford reagent, mix, 
wait 5 min. and read the OD595nm. 
If the OD595nm is out of range (c.a. OD595nm > 2), adjust the concentration of the sample 
by dilution with demineralised H20 or concentration 
3. To know the protein concentration in the sample, defer the OD595nm obtained on the 
calibration curve previously built 
Bradford reagent (for 1 l) 
Product Volume [ml] 
Coomassie Blue G250 0.1 
Ethanol 95 % 50 
Phosphoric acid 85 % 100 
 
 Complete to 1 l with demineralised water 
 Filter before use with Whatman no.1 filter paper (1001-325, Whatman International 
Ltd, Oxon, UK) 
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2.4.4 Overexpression of His6-TrpX protein in E. coli BL21 
pRSETB-X 
2.4.4.1 Overexpression of recombinant protein in E. coli BL21 
E. coli BL21 has a T7 bacteriophage RNA polymerase-based expression system for 
recombinant protein. The plasmid used for the overexpression has been the pRSETB 
containing the coding sequence trpX (pRSETB-X), for 
the recombinant protein His6-TrpX, downstream of the 
T7 promoter (T7pr). The E. coli strain used contains a 
genomic copy of the T7 RNA polymerase (T7pol) under 
the control of the lacUV5 promoter. There is also a T7 
lysozyme encoding plasmid (pLysS), which provides a 
means to inhibit the small amount of T7 RNA 
polymerase that is expressed constitutively, in absence of 
IPTG. pLysS contains also a chloramphenicol-resistance 
(chloR), 
High expression level of the His6-TrpX protein is 
obtained by blocking lacI repressor function by the IPTG 
addition to the media. When IPTG is added to the 
medium, the inhibitor, synthesized by lacI, binds to the 
IPTG and cannot fix any more on the lacUV5 promoter. 
The RNA polymerase produced naturally by E. coli (E. 
coli RNA pol), can transcribe the gene encoding for the 
T7 RNA polymerase. The T7 RNA polymerase binds to 
the T7 promoter (T7pr), the gene trpX is transcribed and 
then translated in the His6-TrpX protein (fig. 13). 
Figure 13   Schematization of genes for  
            tryptophan biosynthesis in  
            S. coelicolor. 
2.4.4.2 Preparation of inocula and induction with IPTG 
Pre-inocula have been prepared with E. coli BL21 w.t., pRSETB and pRSETB-X strains in 
3ml LB medium containing 0.1 g/l ampicillin and 0.025 g/l chloramphenicol. Cultures 
have been put over-night at 37°C. 
For each culture, 2 ml of pre-inoculum has been added to 50 ml LB medium containing 0.1 
g/l ampicillin and 0.025 g/l chloramphenicol. The culture has been put at 37°C until a 
OD590nm ~ 0.4. 
Cultures has been aliquoted in 5x10ml. The overexpression induction of the recombinant 
protein has been made, for culture with E. coli pRSETB-X. Three aliquots have been 
induced with 1 mM of Isopropyl β-D-1-thiogalactopyranoside (IPTG). Two last aliquots, 
of this culture, have been not induced. All aliquots have been cultivated at 30°C during 3h. 
Afterwards, samples have been spin at 4000 g during 10 min. The supernatant (the culture 
medium) has been discarded. If pellets must be stored, freeze pellet at -80°C. 
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2.4.5 Purification of His6-TrpX protein 
The cell lysis and purification of the His6-TrpX protein has been carried out using the kit 
Ni-NTA Purification System (K950-01, Invitrogen, Carlsbad CA, USA). The Ni-NTA kit 
use a chromatographic column, containing an agarose resin, where the nitriltriactetic acid 
(NTA) bind Ni2+ ions through to four coordination sites. The purification of His-tagged 
protein is possible because Ni2+ ions (bound to the matrix) also bind imidazolic rings of the 
histidine of the fusion protein. The purification is carried out in three steps, the step of 
connection between the matrix and the his-tagged protein, the washing step and finally the 
elution step (fig. 14). 
 
     Figure 14   Schematization of genes for tryptophan biosynthesis  
                 in S. coelicolor. 
The manipulation has been carried out following the protocol provided by manufacturer. 
The differences between the manipulation carried out and the original protocol have been 
the use of a 15 ml Falcon tube, instead of a purification column and the elution of proteins 
made in a different way. 
2.4.5.1 Elution of proteins in native conditions 
Elution in native conditions has been not carried out in a continuous, but in a discontinuous 
way. Elution has been carried out in 5 steps, adding every time 1.5 ml of native elution 
buffer pH 8.0, respectively containing 50,100,150,200 and 250 mM Imidazol (from stock 
solution 3M pH 6.0), to the purification matrix, mix and eluate recovery. 
2.4.5.2 Elution of proteins in denaturing conditions 
Elution in denaturing conditions has not been carried out in a continuous, but in a 
discontinuous way. Elution has been carried out in 4 steps, by addition each time of 1 ml of 
denaturing elution buffer pH 4.0, to the purification matrix, mix and eluate recovery. 
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2.4.6 Electrophoretic mobility shift assay (EMSA) 
An electrophoretic mobility shift assay (EMSA), also referred as a gel shift assay, gel 
mobility shift assay, band shift assay, or gel retardation assay, is a common technique used 
to study protein-DNA or protein-RNA interactions in-vitro. 
An EMSA generally involves a electrophoretic separation of a protein-DNA or protein-
RNA mixture, on a polyacrylamide or agarose gel. The rate at which different molecules 
(and combinations thereof) move through the gel is determined by their size and charge, 
and to a lesser extent, their shape. The free (unbound) DNA probe is more fast, than a 
protein-DNA complex. It then appears a shift-up on the gel. For avoid bounds of aspecific 
proteins with the labelled probe, an unlabelled oligonucleotides are added, in excess, to the 
mix (fig. 15). 
The EMSA gel is non denaturing for proteins (native conditions). For visualization 
purposes, the nucleic acid fragment is usually labelled with a radioactive, fluorescent or 
biotin label. 
 
Figure 15 Schematization  
          of a EMSA  
          result. 
 
 
 1 : Control line (free labelled probe) ;  
 2 and 3 : Mix of proteins with  
 labelled probe ; 4 : Mix of proteins  
 with labelled probe and unlabelled 
 oligonucleotides 
 
 
 
 
 
 
2.4.6.1 Preparation of an EMSA 
After preparation and casting of the EMSA gel, it must be left over night at room 
temperature, to guarantee a complete gel polymerization. 
Non denaturing EMSA Gel 5% (for 50 ml) 
Product Volume [ml] 
H20 demineralised 36.3 
Acrylamide Mix 30% 8.3 
TBE 5X 5 
Ammonium persulphate 10% 0.4 
TEMED 0.02 
TBE buffer 5X (Tris-Borate-EDTA) 
54 g Tris BASE, 27.5 g Boric acid and 32 ml EDTA (0.5 M, pH8.0) 
 Complete to 1 L with demineralised water 
 Adjust the pH to 8.3 
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2.4.6.1.1 Preparation of protein extracts 
The crude extracts has been obtained by lysis of cells in the CRACK buffer, cell pellets 
have been ressuspended in 2.5 ml of CRACK buffer and lysis has been made by 
sonication, with 10 cycles of 15s impulses followed by 15s on ice. Lysates obtained have 
been centrifuged 10 min at 3000 g and the supernatant has been recovered. The supernatant 
has been then dialysed, in order to desalt it, in a dialysis tube (Neflex membrane 45, 358-
263-610, Union Carbide Corporation, Chicago IL, USA), which have been put in a 
demineralised water bath for 2h at 4°C. After 2h, demineralised water has been changed 
and the second dialysis has been carried out over night at 4°C. A third and last dialysis has 
been made for 2h at 4°C in fresh demineralised water. Thereafter, samples in the dialysis 
tubes have been recovered. 
Proteins have been quantified by Bradford Assay and for all samples, a 100 µl aliquot 
containing 30 µg/ml proteins has been prepared. 
CRACK Buffer 
10 mM Tris HCl, 0.5 mM EDTA pH 8 and 0.3 mM DTT 
2.4.6.1.2 Preparation of the labelled probe 
The targeted DNA, on which to carry out the analysis, is amplified and labelled by PCR, 
with the radioactive, EasyTides® Deoxycytidine 5’.triphosphate [α-32P]- 
(NEG513Z250UC, PerkinElmer, Boston MA, USA). Master mix composition and PCR 
conditions are shown thereafter : 
Master mix (for 1 sample) 
Product Concentration Volume [µl] 
Buffer Taq 10X 5 
Magnesium chloride (MgCl2) 50 mM 2 
dNTP 10 mM 1 
Primer forward - 1 
Primer reverse - 1 
Taq Polymerase 5 U/µl 0.5 
DMSO - 5 
[α-32P]-dCTP 222 TBq/mmol 3 
H2O demineralised - 30.5 
Final volume - 49 
 Add 1 µl of S. coelicolor genome DNA 
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Temperature and times of PCR steps 
5 min at 95°C → Initial denaturation 
N° Temp. [°C] 
Time 
[s] N° 
Temp. 
[°C] 
Time 
[s] N° 
Temp. 
[°C] 
Time 
[s]  
1 95°C 45 7 95°C 45 13 95°C 45  
2 72°C 45 8 68°C 45 14 64°C 45  
3 72°C 45 9 72°C 45 15 72°C 45  
4 95°C 45 10 95°C 45 16 95°C 60 
5 70°C 45 11 66°C 45 17 62°C 60 
6 72°C 45 12 72°C 45 18 72°C 60  
 
To eliminate not used radioactive and primers in the PCR products, a G25 column 
(illustra™ MicroSpin™ G-25 Columns, 27-5325-01, GE Healthcare, Bukinghamshire, 
UK) has been used, following the manufacturer’s protocol. 
2.4.6.1.3 Preparation of samples 
To allow protein-DNA bounds, a binding reaction mix has been carried out, according to 
the following composition (for 1 sample) : 
 
Product Volume [µl] 10X BB 
MgCl2 0.1M 1 Product Concentration 
Glycerol 50% 1 Tris HCl pH 7.5 12.5 mM 
10X BB 2 Glycerol 10% 
Salmon Sperm (SS) 1 Potassium Chloride (KCl) 62.5 mM 
H20 demineralised 3 
 
Dithiothreitol (DTT) 0.75 mM 
 Salmon sperm, D-1626, Sigma, St-Louis, USA. 
10 µl of proteins extracted, at a concentration of 30 µg/ml (determined by Bradford Assay) 
has been added to the reaction mix and samples have been kept 15 min on ice. Afterwards, 
2 µl of the radioactive labelled probe has been added to each samples, for a final volume of 
20 µl and a sample radioactivity emission between 30 Bq·cm-2 and 80 Bq·cm-2 (if the 
radioactivity of the sample are too much or not sufficiency, it’s possible to adjust the 
volume of labelled probe, adjusting the volume of H20 demineralised into the initial 
reaction mix). Sample have been kept on ice during 20 min. After this step, 1 µl of Dye has 
been added to each samples, to show the progress of the electrophoretic run. Now samples 
are ready to use for the electroporetic run. 
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2.4.6.2 EMSA gel electrophoretic run 
The EMSA gel electrophoretic run has been carried out using as running buffer, TBE 0.5x. 
Before the electrophoresis run, a pre-run during 20 min, without sample charged, has been 
carried out, to permit a good repartition of the running buffer (TBE 0.5X) and a uniform 
composition of the EMSA gel. 
Afterwards samples have been charged on the gel : 
 21 µl of protein samples prepared as shown previously 
 The labelled probe :  
16 µl H20 demineralised + 2 µl glycerol 50% + 2 µl labelled probe + 1 µl Dye 
The gel run has been made at 40 mA. 
2.4.6.3 Revelation of the EMSA gel 
After the EMSA gel run, the gel has been removed from the support. For that, glass plates 
framing have been separated and a Whatman 3MM paper has been applied on the gel. It 
thus remains “stuck” to the Whatman 3MM paper and can now be moved. The gel then has 
been dried in a vacuum gel dryer (GD2000, 80-6428-46, Amersham Pharmacia Biotech 
AB, San Francisco CA, USA) at 60°C during 1h, directly on the sheet of Whatman 3MM 
paper which has been used to remove it from the glass support. Thereafter, the Whatman 
3MM paper has been fixed, using adhesive tape, in a leaded frame and a radiosensitive 
film (Amersham Hyperfilm™ MP, 28906850, GE Healthcare, Buckinghamshire, UK) has 
been placed on the top. The exposure is done at -80°C during a variable time, according to 
the radioactivity emission. 
After exposure of radiosensitive film, it has been developed in a development bath until 
clear appearance of various bands and then wash in a water bath. Afterwards, it has been 
put 15 min in a fixing bath. A final washing in a water bath has been finally carried out. 
The radiosensitive film has been dried at 37°C. 
 Development solution : Kodak® Processing chemicals for autoradiography films, 
GBX developer/replenisher, P7042, Sigma-Aldrich, St. Louis MO, USA. 
 Fixer solution : Kodak® Processing chemicals for autoradiography films, GBX 
fixer/replenisher, P7167, Sigma-Aldrich, St. Louis MO, USA. 
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2.5 RNA methods 
2.5.1 RNA extraction from E. coli 
2.5.1.1 RNA extraction from E. coli with hot SDS/Phenol protocol 
1. Warm 1 volume (based on final volume of cells, media and lysis solution) of 
phenol/chloroform to 65°C 
2. When culture has reached desired O.D., bring 0.5 volume of SDS lysis solution (i.e. 
5ml of lysis solution for 10ml of culture) to 100°C in a Falcon tube for 5 minutes 
3. Quickly add the appropriate volume of cells (typically 10-15ml) directly into 
boiling lysis solution 
Instant lysis of cells using hot SDS quickly inactivates endogenous RNases. This 
can be very important due to the extremely short half-life of many E. coli mRNAs 
and is of particular importance when time-course studies are performing 
4. Keep at 100°C for 5 min. with occasional mixing 
5. Pour this sample directly into 65°C phenol/chloroform seal and parafilm cap (to 
avoid phenol escaping tube during mixing) and mix well by vortexing at high 
speed. 
6. Keep at 65°C for 10 min. with periodic vortexing 
7. Spin the sample at 2500 g during 15 min. 
8. Carefully transfer aqueous phase (avoiding any of the white interface) to fresh 50ml 
tube and add an equal volume of phenol/chloroform 
9. Seal cap with parafilm and mix well by vortexing at high speed 
10. Spin at 2500 g during 15 min. 
11. Carefully transfer aqueous phase to fresh 50 ml Falcon tube and add an equal 
volume of chloroform/isoamyl alcohol 
12. Seal cap and mix well by vortexing 
13. Spin at 2500 g during 15 min. and put aqueous phase in a 30 ml corex tube and add 
an equal volume of isopropanol 
14. Keep at -20°C at least 2 hrs or overnight 
15. Spin down RNA at 15-20000 g during 20 min. at room temperature 
16. Dry the tube in a Speed Vacuum for 30 min 
It is possible air dry the tube on a piece of paper at room conditions 
SDS lysis solution : 
2% SDS and 16 mM EDTA pH 8 
 Optional : add 200 mM NaCl if cells are grown in low salt medium like LB 
Medium 
 Sterilise at 121°C for 20 min. 
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2.5.1.2 DNase treatment of RNA extracts 
The DNase treatment of total RNA extracts is critical remove contaminating genome or 
plasmid DNA from RNA samples. In fact, genome or plasmid DNA can be used as 
template by Taq polymerase during a RT-PCR or a Real-Time PCR. 
Solutions used for the DNase treatment are provided with the kit DNA-free™ (1906, 
Ambion INC., Austin TX, USA). The reaction mix was the following : 
180 µl RNA, 20 µl 10X DNase 1 Buffer and 2 µl DNAse 
The reaction mix has been keep at 37°C during 2h30. After this step, RNA extracts have 
been purified, from DNAse enzyme, by phenol-chloroform extraction. 
2.5.2 Real-Time RT-PCR 
The real-time polymerase chain reaction (Real-Time PCR), also called quantitative real 
time polymerase chain reaction (qRT-PCR) or kinetic polymerase chain reaction, is a 
laboratory technique based on polymerase chain reaction, which is used to amplify and 
simultaneously quantify a targeted DNA molecule. It enables both detection and 
quantification (as absolute number of copies or relative amount when normalized to DNA 
input or additional normalizing genes) of a specific sequence in a DNA sample. 
The procedure follows the general principle of polymerase chain reaction; its key feature is 
that the amplified DNA is quantified as it accumulates in the reaction in real time after 
each amplification cycle. Two common methods of quantification are the use of 
fluorescent dyes that intercalate with dsDNA, and modified DNA oligonucleotide probes 
that fluoresce when hybridized with a complementary DNA. 
Frequently, real-time polymerase chain reaction is combined with reverse transcription 
polymerase chain reaction to quantify low abundance mRNA, enabling a researcher to 
quantify relative gene expression at a particular time, or in a particular cell or tissue type. 
2.5.2.1 cDNA preparation from RNA extracts 
RNA extracts have been reverse transcripted in DNA, for easiest sample manipulations and 
better storage. cDNAs have been obtained by PCR, using the High Capacity cDNA 
Reverse Transcription Kit (P/N 4368814, Applied Biosystems, Foster City CA, USA). The 
PCR has been carried out by 10 min at 25°C (annealing), 120 min at 37°C (DNA 
extension) and 5 min at 85°C (RT enzyme inactivation), using the thermocycler 
Tpersonal® (050-550, Biometra, Goettingen, Germany), in the following master mix : 
 
 
Product Volume [µl] 
Buffer 10X 5 
dNTP 10 mM 8.3 
Random primers 5 
Reverse transcriptase 2.5 
RNA inhibitor 2.5 
RNA 300 ng/µl 2 
Demineralised water 31 
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2.5.2.2 Real-Time RT-PCR 
The Real-Time PCR has been carried out using Power SYBR® Green PCR Master Mix 
(P/N 4309155, Applied Biosystems, Foster City CA, USA), in the following master mix : 
 
Product Volume [µl] 
Primer forward 100 pM 2.5 
Primer reverse 2.5 
SYBR® Green 12.5 
cDNA 5 ng/µl 2.5 
Demineralised water 2.5 
 
The Real-Time PCR has been made in the 7300 Real Time PCR system (4351103, Applied 
Biosystem, Foster City CA, USA). 
The thermic profile used begin with a hot start (initial denaturation) at 95°C during 10 min, 
and 40 cycles of 15s at 95°C (denaturation) and 1 min at 60°C (primers annealing and 
DNA extension). 
The analysis of amplified DNA fragments is based on the fluorescence variation in each 
samples. The fluorescence detected correspond to the SYBR® Green emitted fluorescence. 
The SYBR® Green bind stoichiometrically to dsDNA only, and it emit fluorescence only 
after bound to nucleic acid. 
The detector subtracts the passive emitted fluorescence (Baseline) in the sample, from the 
total fluorescence detected. The fluorescence augmentation (ΔRn), correlated to amplified 
fragment amount, in function of amplification cycles represents the “amplification plot”, a 
logarithmic curve. 
Amplified sample analysis is made using the Sequence Detection Software (SDS), Version 
1.2.3 (7000 System SDS Software, Applied Biosystems, Foster City CA, USA). 
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3 Aims of this work 
3.1 General purpose of the work 
3.1.1 The increase of antibiotic production in S. coelicolor 
A3(2) 
The emergence of several pathogenic bacteria and the adaptation of part of those resistant 
to antibiotics currently used, in clinically treatments, needs the research for new antibiotic 
development. ActinoGEN is an European project for the discovery of new antibiotics and 
the construction of a “Superhost” for their industrial scale production. Organisms, on 
which this research is based, are the actinomycetes, and more specifically Streptomyces 
genus. Actinomycetes are known to produce approximately 6000 different antibiotics (half 
of those currently known). 
The Streptomyces coelicolor genome having been completely sequenced (Bentley SD, 
2002), allowed the identification of many genes involved in the secondary metabolite 
biosynthesis. This allowed the discovery as well as the regulation knowledge of various 
biosynthetic clusters for secondary metabolites. In particular, the CDA biosynthetic cluster 
in Streptomyces coelicolor has been well studied and represent about 1% of total genome. 
(Hojati Z, 2002). 
The CDA is one of a natural peptide family produced by non-ribosomal way, like the 
cyclosporin (immunosupressor), the bleomycin (antitumor) and the vancomycin 
(antibiotic). Antibiotics of this family are used against gram-positive pathogenic bacteria 
resistant to common antibiotic treatments.  
The CDA cluster contains some genes involved in the tryptophan pathway (trpC2, trpD2, 
trpE2 and trpG), tryptophan being a CDA precursor (Kim HB, 2004). Two strategies, 
aimed to increase the CDA production, are the overexpression of genes involved in the 
tryptophan biosynthesis and the mutation of genes involved in its catabolism. These two 
strategies could allow an accumulation of tryptophan in the cell, carrying to a major 
production of CDA (fig. 16). 
 
 
 
Figure 16   Strategies to  
            increase CDA  
            production in  
            S. coelicolor. 
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3.1.2 The trpX orf in S. coelicolor A3(2) 
One of fundamental operons for the tryptophan biosynthesis is the trpA/B/X/C1 operon 
(fig. 17). 
 
Figure 17  trpA/B/X/C1 operon in S. coelicolor. 
This cluster contains the small trpX orf, having to date any known function. The trpX 
orf (also called SCO2038), codes for a hypothetical 63 amino acids protein, with a mass 
weight of 7167 Daltons and a pI of 11.754. The small orf presence among important genes 
implied in a amino acids biosynthesis does not constitute an isolated case. Indeed, small 
orfs are present also between proA and proB genes, involved in the proline synthesis 
(Hood DW, 1992), and in principal operons involved in the histidine synthesis (Limauro D, 
1990). Moreover, to date, the role of these small orf remains still unknown. This shows the 
importance of elucidating the trpX gene role. This will imply a better comprehension of the 
amino acids synthesis regulation in the S. coelicolor, and more mainly in actinomycetes, 
still poorly understood. 
Previous experiments showed that the S. coelicolor A3(2) ΔX mutant is not able to grow 
on a minimal medium (SMMS), whereas it grows on this same medium after tryptophan 
addition. The mutant S. coelicolor A3(2) ΔX/X grows on a minimal medium, like the strain 
S. coelicolor A3(2) M145 (w.t.). This effect cannot be explained by a simple polar effect, 
due to the trpX gene interruption, which does not allow the trpB gene expression. Indeed, it 
is possible to complement the trpX mutation with the pKCHyg796trpX plasmid, containing 
a w.t. copy of this gene. 
These results show that trpX gene is essential for the S. coelicolor growth in a medium 
where tryptophan lacks, and thus it plays a key role in the tryptophan biosynthesis. 
Real-Time RT-PCR, of the global expression of S. coelicolor A3(2) genes, has shown that 
trpA gene is expressed at the same level, in S. coelicolor M145 and trpX mutants, 
indicating that this gene is not influenced or regulated by trpX gene. 
Microarrays analysis, confirmed by Real-Time RT-PCR, has shown that the trpB gene is 
less expressed in S. coelicolor ΔX and ΔX/pKC mutants, than in M145 strain. When trpX 
mutation is complemented with pKCHyg796trpX plasmid, the trpB shows normal 
expression level. 
These results suggest that the trpB gene is regulated by trpX, and that the trpB-trpX 
intergenic region could contain a promoter allowing trpA and trpB expression. 
3.2 Specific objective of this work 
The specific objective of this work is to start the study of the trpX gene role in 
Streptomyces coelicolor. In particular to: 
1) study the trpX expression in the strain S. coelicolor A3(2) M145, in various growth 
phases and media by qRT-PCR. 
2) perform in silico analysis of protein structure using the Robetta server. 
3) carry out EMSA of intergenic regions of trpA/B/X/C1 operon with crude extract of wt 
and mutant strains. 
4) overexpress and purify TrpX protein from E. coli. 
5) overexpress the trpX gene in S. coelicolor. 
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4 RESULTS 
4.1 Expression of trpA, trpB and trpX in S. 
coelicolor A3(2) M145 
The expression analysis of trpA, trpB and trpX genes, in S. coelicolor A3(2) M145 have 
been carried out by Real-Time RT-PCR, from total RNA extracts. RNAs have been 
extracted from cultures grown in R5 medium, in the RG1 and RG2 growth phases and in 
SMMS medium, in RG, T and S phases (in SMMS medium RG2 phase is absent) (fig. 18). 
 
 
Figure 18  S. coelicolor growth curve in SMMS and R5 medium. Black arrows  
           indicate the time of global RNA extraction. 
RNA extracts, after DNA removing, using DNase, and purification, by phenol-chloroform 
protocol, have been reverse transcribed in cDNA, using the High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems). 
The Real-Time RT-PCR has been carried for trpA, trpB and trpX genes, using three primer 
pairs (table 2). 
Table 2  Real-Time PCR primers 
Targeted gene Primer direction Primer sequences 
Forward 5’-TCCGCGAGGCACACGAGGC-3’ 
trpA 
Reverse 5’-CGGGCAGGTCGGGCAGGAT-3’ 
Forward 5’-GCGCGAGGACCTGAACCACAC-3 
trpB 
Reverse 5’-GGCGGCGGGTGTCGATCT-3 
Forward 5’-CGCTCCCGCTCGTCCC-3 
trpX 
Reverse 5’-CCTGATGGGGCGCTTGA-3 
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The qRT-PCR has been carried out using absolute quantification of the transcripts, and the 
quantification of targeted genes in samples has been obtained using 5 standards, containing 
102, 103, 104, 105 and 106 molecules of S. coelicolor chromosome DNA respectively. The 
cDNA concentration, in each analysed sample was 5 ng/µl. 
Real-Time RT-PCR results, analysed, using the Sequence Detection Software (SDS), 
Version 1.2.3 (Applied Biosystems), are shown in fig. 19. 
 
 
Figure 19  Expression level of trpA, trpB and trpX genes of S. coelicolor 
           A3(2) M145, in R5 medium, during the RG1 and RG2 growth  
           phases, and in SMMS medium, during RG, T and S phases,  
           quantified by qRT-PCR and analysed using Sequence Detection  
           Software (SDS), Version 1.2.3 (Applied Biosystems). 
The trpA expression level decreases during the S. coelicolor A3(2) growth, independently 
of the culture medium used. Nevertheless, it seems sensible to culture medium used. In 
fact, it is less expressed in R5 than in SMMS medium. 
In R5 medium, the trpB expression level decreases during the S. coelicolor A3(2) growth, 
but it remains constant in SMMS medium. The trpB expression level is not influenced by 
the medium used. 
The expression level of trpX gene is showed only for SMMS medium, because of an 
aspecific fragment amplified in R5 medium samples. trpX is more expressed in rapid 
growth (RG) and stationary (S) phases than in transition (T) phase. 
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4.2 Tridimensional structure prediction of TrpX 
with Robetta server 
The TrpX amino acidic sequence has been submitted to the Robetta server 
(http://robetta.bakerlab.org), to have its structure predictions and thus putative functions. 
The amino acid sequence submitted was: 
MTLPLVPARDPYARLARGCRPRGCRAPARRVHGRRVRYVIGDEPGQVNGMRWLKRPIRGAGLY* 
Several protein structure predictions have been found and for each prediction, several 
known protein models have been proposed. Robetta server results are shown, in fig. 20. 
 
    Figure 20  Representation of TrpX model families, obtained by the  
               Robetta server. 
Robetta server protein structure prediction show clearly that a nucleic acid binding protein 
is the most probable model family for TrpX, with 45% of total models obtained. Informatic 
structure prediction cannot be considered as reliable, and thus this gives simply some TrpX 
hypothesis function in S. coelicolor. 
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4.3 Gel mobility shift assays of 32P-end-labeled 
fragments spanning the intergenic region of 
trpA/B/X/C1 operon. 
The TrpX structure prediction, using Robetta server, suggested a DNA-binding role.  
Study on global gene expression carried out by qRT-PCR, in S. coelicolor A3(2), using 
trpX mutants, suggested that trpX could be involved in the trpB gene regulation and also 
that trpB-trpX intergenic region could contain a promoter of trpA/B gene. 
Study on the trpA/B/X/C1 operon have evidenced that trpX-trpC1 intergenic region is a 
promoter of this operon (Hu DSJ, 1999). 
Gel mobility shift assay have been carried out, on trpB-trpX and trpX-trpC1 intergenic 
regions (fig. 21), using crude extracts of S. coelicolor A3(2) wt and trpX mutant strains. 
 
Figure 21  Schematic representation of trpB/X/C1 intergenic regions. 
Protein extracts have been prepared from S. coelicolor A3(2) M145, ΔX, ΔX/X and 
ΔX/pKC strains grown in SMMS and SpMR media. Two samples have been collected, 
after 16h and 42h of growth. S. coelicolor cells have been harvested and resuspended in 2.5 
ml of CRACK buffer, and cell lysis has beencarried out using a sonicator. Proteins have 
been separated from cell debris, by centrifugation and recovery of the supernatant. Then, to 
desalt protein extracts, a dialysis of samples has been carried out. 
Proteins in solution have been quantified by the Bradford assay, and 100 µl aliquots 
containing 30 µg/ml proteins has been prepared, for each strain. 
Radioactive labelled probes have been prepared by PCR amplification of trpB-trpX and 
trpX-trpC1 intergenic regions, from S. coelicolor M145 genome DNA, using primer pairs 
shown in table 3: 
Table 3  Primers used for PCR PCR amplification of trpB-trpX and  
         trpX-trpC1 intergenic regions 
Targeted 
region 
Primer 
direction Primer sequences 
Primers bound 
schematization 
Forward 5’-GGATCGGGGATGAAGAAGTT-3’ 
trpB-trpX 
Reverse 5’-GGTACGTCATCGGAGACGAG-3’  
Forward 5’-CTCGTCTCCGATGACGTACC-3 
trpX-trpC1 
Reverse 5’-GTCGGCGAGTCCCTGGTC-3’  
For each amplification, three samples have been prepared, the negative control without 
DNA (by addition of demineralised water), two samples with S. coelicolor genome DNA, 
with and without dC32TP). Non radioactive samples, after PCR, have been analysed by gel 
electrophoresis 1% (fig. 22). 
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Figure 22  PCR amplification of trpB-trpX (a) and trpX-trpC1 (b) 
           intergenic regions. The negative control (NC) corresponds to  
           PCR master mix without DNA template. The size of analysed DNA  
           fragments has been determined using the Fermentas O’GeneRuler™  
           DNA Ladder Mix (M). 
Amplified DNA fragments have been extracted from the gel using the illustra GFX™ PCR 
DNA and Gel Band Purification Kit (28903466, Ge Healthcare, Buckinghamshire, UK). 
Fragments extracted have been sequenced by BMR Genomics, Padova, Italy using same 
primers used for PCR amplification. Chromatograms received have been analysed using 
Sequence Scanner V1.0 (Applied Biosystems). Sequenced fragment sequences have been 
aligned on the S. coelicolor M145 sequences, using the ClustalX V2.0.3 software (fig. 23). 
 
Figure 23 Sequence alignment, using the ClustalX 2.0.3 software, of  
          sequenced trpB-trpX intergenic region amplified by PCR (a) 
          and sequenced trpX-trpC1 intergenic region amplified by PCR  
          (b). Sequenced sequences have been aligned on the S. coelicolor  
          M145 sequences. 
The sequence alignment shows that amplified trpB-trpX and trpX-trpC1 fragments has the 
correct sequence (fig. 23). 
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Radioactive labelled probes have been purified from primers and free nucleotides through 
a G-25 column.  
EMSA analysis of the trpB-trpX and trpX-trpC1 intergenic region did not revealed any 
shift different from those present in the labeled probe without protein crude extract (fig. 
24). 
 
Figure 24  Gel mobility shift assay of the 32P labelled DNA fragments  
           spanning the intergenic regions trpB-trpX (a) and trpX-trpC1  
           (b)  EMSA was performed using crude extracts from strains  
           S. coelicolor M145 (A), ΔX (B), ΔX/X (C) and ΔX/pKC (D) grown 
           in SMMS or SpMR medium. P lanes correspond to free probe. 
This results obtained showed that, in the used conditions, there are no proteins bound to the 
intergenic regions analysed. 
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4.4 Overexpression of TrpX in E. coli BL21 
One objective of this work was to obtain the purified TrpX protein, in order to use it in 
EMSA assay. 
The strategy choosed for the TrpX protein overexpression involves the use of pRSETB 
plasmid. The pRSETB plasmid has been constructed for the recombinant protein 
overexpression in E. coli BL21, allowing its control and a easy purification of the 
overexpressed protein. 
The first step of this strategy is the construction of the pRSETB-X plasmid in E. coli 
DH5α, followed by the E. coli BL21 transformation with the constructed plasmid. 
4.4.1 Cloning of SCO2038 in pRSETB 
The trpX gene has been amplified, from S. coelicolor A3(2) M145 genome, by PCR with 
following primer pair : 
 
Forward 5’- AAAGGATCCTATGACGCTCCCGCTCGTCC -3’                    BamHI 
SCO2038 
Reverse 5’- AAAAAGCTTTCAATACAGCCCCGCGCCCCT -3’                   HindIII  
 
This primer pairs add HindIII and BamHI restriction sites and polyA tags at the 5’-end of 
the amplified fragment. PolyA tag allows an easier binding of the restriction enzyme. The 
PCR product has been analysed by gel electrophoresis 1% (fig. 25)  
 
Figure 25  Gel electrophoresis 1% of PCR product  
          (1). The size of analysed DNA fragments  
           has been determined using the Fermentas  
           O’GeneRuler™ DNA Ladder Mix (M). 
 
The 210 bp amplified fragment, corresponding to trpX gene, has been purified, from the 
gel matrix, using the illustra GFX™ PCR DNA and Gel Band Purification Kit (28903466, 
Ge Healthcare, Buckinghamshire, UK). 
The pRSETB plasmid has been extracted, from a E. coli BL21 pRSETB culture in LB 
medium, containing 0.025 g/l chloramphenicol. After extraction, it has been digested with 
HindIII and BamHI. 
Amplified and purified trpX and pRSETB have been digested with BamHI and HindIII 
restriction enzymes. After digestion of pRSETB, an alkaline phosphatase treatment has 
been carried out in order to avoid self-ligation of the vector. The trpX cloning in pRSETB 
has been carried out by ligation reaction, using an insert-vector ratio of 3:1. 
                           Diploma 2007                  
 
 
Ledda Mirko                                            04.03.2008                                                  47 / 57 
 
4.4.2 E. coli DH5α transformation with pRSETB-X 
E. coli DH5α electrocompetent cells have been transformed with the ligation mixture. 
After electroporation cells have been selected on plates containing 0.1 g/l ampicillin. 
Twentyfour clones have been selected for further analysis. Plasmids from these selected 
clones have been extracted by MiniPrep. The restriction pattern of extracted plasmids has 
been carried out using DraI and BamHI restriction enzymes. Fragments has been analysed 
by gel electrophoresis 1% (fig. 26). 
 
 
Figure 26  Expected fragments after DraI digestion of pRSETB and pRSETB-X  
           plasmids (a). Gel electrophoresis 1% of extracted plasmids  
           after digestion with KpnI (b) (lanes 1-17). The size of  
           analysed DNA fragments has been determined using the Fermentas  
           O’GeneRuler™ DNA Ladder Mix (M). 
DraI digestion of extracted plasmid, after gel electrophoresis, shows the two expected 
fragments (692 bp and 2119/2279 bp), the third one being not visible due to its small size 
(19 bp) (fig. 26). Seven E. coli DH5α clones, containing a plasmid with expected 
fragments (fig. 31, lanes 2, 7, 9, 11, 14, 15 and 17), have been selected. From this selected 
clones, a plasmid extraction with the GenEluteTM Plasmid Miniprep Kit (Invitrogen), has 
been carried out. These plasmids have been sequenced by BMR Genomics, Padova, Italy, 
using primers which allow the amplification of DNA cloned in pRSET the trpX gene. 
Chromatograms received have been analysed using Sequence Scanner V1.0 (Applied 
Biosystems).  
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The sequence alignment shows that three out of four E. coli DH5α pRSETB-X clones, 
contain the pRSETB-X plasmid with the correct trpX gene sequence. Two out of three 
clones (called pRSETB-X2 and pRSETB-X24) has been selected to transform E. coli 
BL21 cells, after plasmid extraction. 
4.4.3 Transformation of E. coli BL21 with pRSETB-X 
plasmid 
E. coli BL21 electrocompetent cells have been transformed with the pRSETB-X2 and 
pRSETB-X24 plasmids, extracted from E. coli DH5α, by electroporation. Cells have been 
cultivated on selective plates containing 0.025 g/l chloramphenicol and 0.1 g/l ampicillin, 
for clone screening.  
4.4.4 TrpX purification from E. coli cells 
In order to purify His6-TrpX, an E. coli BL21 pRSETB-X24 culture has been grown at 
37°C until a OD590nm =0.4 has been reached. Later, the culture has been splitted in three 
subcultures and grown 
1) 37°C, 3h 
2) 37°C, 3h; 0,1 mM IPTG 
3) 37°C, 3h; 1 mM IPTG 
Then, the medium has been removed from cells by centrifugation at 3000 g. 
4.4.4.1 Cell lysis and His6-TrpX purification in native conditions 
Cells have been thereafter lysed by sonication in the native buffer (see Ni-NTA 
purification system, Invitrogen). A centrifugation has been carried out to separate soluble 
proteins from cells debris and insoluble proteins. SDS-PAGE analysis has been carried out 
with soluble proteins of E. coli BL21 pRSETB-X24 strain (fig. 27). 
 
 
Figure 27  SDS-PAGE of native and soluble proteins extracted from E. coli  
           BL21 pRSETB-X24 not induced (1-2) or induced with 1 mM IPTG  
           (3). 
SDS-PAGE analysis of native and soluble protein extracts (fig. 34) revealed the induction 
of a 8-9 kDa protein. This protein is present in fact only in strain harbouring the pRSET-
X24 plasmid. Purification of the protein is in progress.  
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4.5 trpX gene overexpression in S. coelicolor 
One objective of this work was to overexpress the trpX gene in S. coelicolor, in order to 
study differences in the global gene level expression and antibiotic level production, 
between mutant and wt strains, indicating ways to understand the trpX gene role. 
The strategy choosed for the trpX gene overexpression involves the use of pIJ8600 
plasmid. The pIJ8600 plasmid has been constructed for the integration of a gene in S. 
coelicolor genome, followed by its overexpression. 
The first step of this strategy is the construction of the pIJ8600-X plasmid in E. coli DH5α. 
 
The pGEM-X plasmid has been extracted, from a E. coli DH5α pGEM-X culture in LB 
medium, containing 0.1 g/l ampicillin. The trpX gene has been obtained by digestion of the 
extracted pGEM-X plasmid with BamHI and NdeI restriction enzymes.  
The pIJ8600 plasmid has been extracted, from a E. coli DH5α pIJ8600 culture in LB 
medium, containing 0.05 g/l apramycin. After extraction, it has been digested with BamHI 
and NdeI. After digestion of pIJ8600, an alkaline phosphatase treatment has been carried 
out in order to avoid self-ligation of the vector. 
The trpX cloning in pRSETB has been carried out by ligation reaction, using an insert-
vector ratio of 3:1. 
 
E. coli DH5α electrocompetent cells have been transformed with the ligation mixture. 
After electroporation cells have been selected on plates containing 0.05 g/l apramycin. 
Two hundred clones have been selected for further analysis. Clones have been used in 
colony pool PCR, using 10 clones per PCR tubes, and amplified fragments have been 
analysed by gel electrophoresis. The colony pool PCR has been carried out using the 
following primer pair : 
 
Forward 5’-AAACATATGACGCTCCCGCTCGTCC-3’                           NdeI 
SCO2038 
Reverse 5’-AAACCTAGGTCAATACAGCCCCGCGCCCCT-3’                  BamHI  
 
The gel electrophoresis of colony pool PCR products have not shown a 210 bp amplified 
fragment, corresponding to the amplified trpX gene. Clones obtained contains only the 
pIJ8600 without trpX insert. 
 
Three other E. coli DH5α transformations, changing insert-vector ratio or using E. coli 
DH5α calcium-competent cells, transformed with the corresponding protocol, has been 
made. Clones have been screened but no positive E. coli DH5α pIJ8600-X clone has been 
found. 
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5 DISCUSSION 
5.1 Expression of trpX gene in S. coelicolor 
Real-Time RT-PCR analysis of S. coelicolor M145 gene expression, carried out during this 
work, showed that trpX is not costitutively expressed during the growth in SMMS medium 
(minimal medium). In fact, this gene is less expressed in the transition phase than in rapid 
growth and stationary phases. These results are in agreement with those reported by 
Hodgson DA, 2000. In fact the expression of many S. coelicolor genes involved in amino 
acid biosynthesis is growth-phase dependent. 
5.2 Putative function of TrpX protein in S. 
coelicolor 
In silico approaches and previous experiments have shown that TrpX protein is a putative 
regulator of the trpB gene, a gene involved in the tryptophan biosynthesis. Microarray 
analysis, confirmed by Real-Time RT-PCR, of S. coelicolor trpX mutants showed that trpB 
gene expression in trpX mutant is lower than the one observed in wt strain. When mutation 
is complemented, trpB expression level is similar to that of wt strain.  
A tridimentional structure prediction, using a predictional software has been carried out, 
and it showed that TrpX protein has a DNA-binding protein structure.  
These in silico results suggested that TrpX could bind to DNA. 
5.3 Gel mobility shift assays (EMSA) of 32P end 
labelled fragments spanning intergenic 
regions of trpA-B-X-C1 operon. 
The most probable hypothesis of the TrpX protein function in S. coelicolor, is that it binds 
to intergenic regions of the trpA/B/X/C1 operon, such as trpB-trpX and trpX-trpC1 
intergenic regions, regulating the trpB gene expression. 
Two EMSA have been carried out, during this work, using protein extracts of S. coelicolor 
M145, ΔX, ΔX/X and ΔX/pKC strains. Results showed that no proteins are bound to the 
two regions, in the used conditions.  
Further EMSA analysis is necessary, changing some parameters of the assay. 
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5.4 TrpX protein overexpression in E. coli 
To understand TrpX protein function in S. coelicolor, its overexpression and purification 
were carried out using a E. coli BL21 pRSETB-X strain. 
The strategy choosed for the SCO2038 protein overexpression involves the use of pRSETB 
plasmid. The pRSETB plasmid has been constructed for the recombinant protein 
overexpression in E. coli BL21, allowing the control of its expression and an easy 
purification of the overexpressed protein. 
The E. coli DH5α pRSETB-X, and successively the E. coli BL21 pRSETB-X24 strains 
have been successfully constructed and controlled. The His6-TrpX protein was successfully 
overproduced and its purification at present is in progress. The protein will be used in 
DNA or RNA binding assays. 
5.5 trpX gene overexpression in S. coelicolor 
One objective of this work was to overexpress the trpX gene in S. coelicolor, in order to 
study differences in the global gene level expression and antibiotic level production, 
between mutant and wt strains, indicating ways to understand the trpX gene role. 
To understand trpX gene function in S. coelicolor, its overexpression in S. coelicolor was 
carried out using the pIJ8600-X plasmid. The strategy choosed for the trpX gene 
overexpression involves the use of pIJ8600 plasmid. The pIJ8600 plasmid has been 
constructed for the integration of a gene in S. coelicolor genome, followed by its 
overexpression. 
The first step of this strategy is the construction of the pIJ8600-X plasmid in E. coli DH5α. 
 
E. coli DH5α cells has been transformed with the pIJ8600-X plasmid, but no positive clone 
has been found, also changing cell transformation conditions. 
 
Other strategies to obtain the trpX gene overexpression in S. coelicolor have been studied. 
Two new strategies have been selected, and each involved the construction of the E. coli 
DH5α pIJ8600-pGEM-X stain. The advantage of these strategies is the clone screening 
using plates containing two antibiotics, apramycin (gene resistance present in pIJ8600) and 
ampicillin (gene resistance present in pGEM), avoiding the growth of strains containing 
only the pIJ8600 plasmid without trpX insert. 
First one involved the pIJ8600-pGEM-X plasmid direct integration in the S. coelicolor 
genome. 
Second one involved the suppression of the pGEM fragment in the pIJ8600-pGEM-X 
plasmid, using restriction enzymes, to obtain the targeted E. coli DH5α pIJ8600-X stain. 
This two strategies at present are in progress. 
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6 CONCLUSIONS AND PERPECTIVES 
Real-Time RT-PCR analysis showed that trpX is not costitutively expressed during the 
growth in minimal medium, but is growth-phase dependent. 
In silico approaches and previous experiments have shown that TrpX protein is a putative 
regulator of the trpB gene, a gene involved in the tryptophan biosynthesis and a 
tridimentional structure prediction showed that TrpX protein could have a DNA-binding 
protein structure.  
The most probable hypothesis of the TrpX protein function in S. coelicolor, is that it binds 
to intergenic regions of the trpA/B/X/C1 operon, regulating the trpB gene expression. 
This hypothesis has not been confirmed by DNA binding assays carried out in this work, 
thus, further DNA or RNA binding assays, are necessary. 
The His6-TrpX protein was successfully overproduced in E. coli, and its purification at 
present is in progress, it will be used in DNA or RNA binding assays, in order to confirm 
the previous hypothesis. 
To understand trpX gene role in S. coelicolor, it has been overexpressed in S. coelicolor, in 
order to study differences in the global gene level expression and antibiotic level 
production, between obtained mutant and wt strains. This strategy indicating ways to 
understand the trpX gene role in S. coelicolor. Nevertheless, the trpX gene overexpression 
in S. coelicolor was unsuccessfully. The pIJ8600-X plasmid used for the trpX gene 
overexpression, has not been constructed in E. coli DH5α. 
New strategies has been studied and at present are in progess. 
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